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SUMMARY
The work for this thesis has been inspired by the 
experience gained from managing patients with 
inflammatory bowel disease in a specialist centre. An 
increasing number of patients with Crohn's disease are 
now surviving repeated intestinal resections which 
result in a short residual intestine. These patients, 
and others who have undergone extensive bowel resection 
secondary to mesenteric vascular disease, neoplasia, or 
radiation damage may develop a variety of nutritional 
deficiencies.
Those least affected have a tendency to water and sodium 
depletion requiring oral or parenteral replacement while 
being able to nourish themselves satisfactorily in the 
normal way. In the most extreme cases, insufficient 
bowel remains for satisfactory nutritional function, and 
parenteral nutrition in the patient's home is necessary 
to sustain life.
This thesis describes the clinical and pathophysio­
logical features of the short bowel syndrome, and 
reviews the current state of knowledge regarding the use 
of fluid and electrolyte replacement and dietary 
manipulation in the management of such patients. The 
use of supplementary liquid diets and the techniques and
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problems of home enteral and parenteral nutrition are 
discussed.
Experimental work has been undertaken with a group of 
patients who suffered from varying disabilities due to a 
short small intestine. The problems of fluid and 
electrolyte balance have been studied by comparing the 
efficiency of different sugar-electrolyte mixtures in 
improving sodium and water balance. This work was 
performed in collaboration with Dr C R Newton at St 
Mark's Hospital.
In a series of dietary studies, a whole protein liquid 
diet has been compared with a chemically defined diet, 
and with solid food by measuring nitrogen, fat and 
calorie balances. The effects of varying the fat and 
fibre content of normal diets upon these parameters, and 
upon sodium, potassium, calcium and magnesium balance 
have been investigated.
During the investigation and treatment of these 
patients, techniques for enteral and parenteral 
nutrition in the home have been developed and refined. 
These techniques and their complications are described 
and the results of therapy on patients' medical and 
social state presented.
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In the final discussion, the experimental results are 
drawn together and their relevance to clinical practice 
is discussed. Guidelines for the oral, enteral and 
parenteral electrolyte and nutritional support of 
patients with the short bowel syndrome are suggested.
The appendix to the thesis contains case histories of 
those patients who took part in the studies of 
electrolyte mixtures, solid diets, and liquid 
supplements given orally and by nasogastric tube.
15
INTRODUCTION
Definition of the Short Bowel Syndrome
The 'short bowel syndrome' is a relatively new term 
which has gained general acceptance in
gastroenterological and surgical practice as a 
convenient label to describe the symptoms and 
pathophysiological disorders brought about by the 
surgical removal of a large proportion of the intestine 
without regard to the underlying disease.
Prior to the early 1960's the term does not seem to 
appear in the literature, and patients with what is now 
called the short bowel syndrome were described as having 
had 'massive' intestinal resections. The adjectives 
'massive' and 'extensive' were used to indicate 
resection of more than 200cm of intestine. This length 
was decided upon early in the literature as it was 
thought to represent approximately one third of the 
total length of the small intestine, which Senn in 1888 
had experimentally demonstrated to be the maximum which 
could safely be removed (230). The convention persisted 
for over seventy years (93,206). The question of how 
much intestine is required to sustain life received much 
attention, and two papers, by Flint in 1912 (71) and 
Haymond in 1935 (93) stand out as major contributions.
16
Flint (71) demonstrated experimentally that dogs could 
withstand removal of 50% of the intestine and regain 
normal health, but that when 75-80% was removed a normal 
state was never achieved although survival was possible. 
Using microscopic techniques he demonstrated hypertrophy 
of the intestinal villi and calculated a four-fold 
increase in the absorptive surface after resection. In 
theoretical terms, he suggested that 25% of the 
intestine might be able to adapt sufficiently to provide 
normal digestive function.
In 1935 Haymond (93) published an extensive review which 
included data on 1161 cases in whom the intestine had 
been measured at surgery or at necropsy. The mean 
length was found to be 657cm vindicating the concept 
that 'massive' resections removed one third of the 
intestine. The range of length however was vast, from 
304cm to 1216cm. The analysis of 257 cases of massive 
resection prompted the conclusions that normal 
intestinal function can be expected after a 33% 
resection, that 50% is the upper limit of safety, and 
that resection of greater than 50% of the small bowel 
will generally result in poorer results although there 
will be exceptions. That these exceptions occurred is 
shown by the large number of anecdotal case reports 
which appear throughout the literature (9,25,27,46,71,91 
93,113,137,152,165,170,225,237,255,270,273,277).
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Causes
It is interesting to compare the common causes of the 
short bowel syndrome today with those which were 
responsible in the early decades of the twentieth 
century. Haymond (93) found the three most common 
causes of massive resection to be volvulus, strangulated 
hernia, and mesenteric thrombosis. Volvulus was 
subdivided into two very different groups, simple small 
intestinal volvulus and a condition known as 
Knotenbildung in which knot formation involved the 
sigmoid colon and ileum. In eleven cases massive 
resection followed intestinal damage at the time of 
criminal abortion, and tuberculosis was responsible in 
sixteen cases, with trauma and miscellaneous pathologies 
accounting for the remainder.
Although it is just over fifty years since regional 
enteritis gained the eponym 'Crohn's Disease', it has 
become one of the major causes of the short bowel 
syndrome. By its very nature as a chronic inflammation 
of the intestine characterised by intermittent 
exacerbations and the tendency to cause structural 
complications such as abcesses, fistulae and strictures, 
Crohn's disease often requires repeated surgery of the 
large and small bowel although a cure is never achieved. 
It would be unfair, and inaccurate, to hold the increase
18
in Crohn's disease wholly responsible for the increased 
incidence and interest in the short bowel syndrome. 
Acute vascular incidents both arterial and venous
continue to necessitate the resection of the majority of 
the intestine as an emergency procedure. The increase 
in atherosclerosis generally has been accompanied by 
bowel infarction in some patients although this is 
usually part of a generalised arteriopathy and affects 
the older age groups. Of more concern has been the 
increase in venous catastrophies in young women 
associated with the increased use of oral contraceptive 
preparations. The advent of the regular use of 
radiotherapy in the treatment of pelvic and intra­
abdominal neoplasia has brought with it a steady, if 
low, incidence of radiation enteropathy which may
require intestinal resection (11,48,86,124,172,274).
Management
Since the mid 1960's more emphasis has been placed on 
the length of remaining bowel rather on that of the 
resected segment. Figure 1 demonstrates the intestinal 
brevity and rapid intestinal transit which are typical 
of patients with the short bowel syndrome. Increased 
understanding of the mechanisms of absorption 
(6,7,23,27,28,227) and the identification of specific 
sites for the absorption of individual nutrients
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(22,24,25,29) led to more interest being taken in the 
type of bowel remaining. These experimental studies 
coupled with the anecdotal reports previously mentioned 
laid the foundations for the dietary manipulations which 
remain the mainstay of management (86,107,124,172). 
Increased understanding of nutritional requirements and 
the development of nutritional supplements and elemental 
diets has provided more alternatives in dietary 
practice. The development of safe and efficient 
techniques for tthe long term administration of 
intravenous fluids has established parenteral nutrition 
at home as a routine part of the medical repertoire 
which is now available at some centres.
This thesis has been planned and prepared to study and 
discuss some of the varied problems which face patients 
and their doctors dealing with the short bowel syndrome.
20
CLINICAL FEATURES OF THE SHORT BOWEL SYNDROME
The short bowel syndrome may be associated with any or 
many of a wide range of symptoms and pathophysiological 
features. The exact combination of fluid, electrolyte 
and nutritional problems experienced by any individual 
patient will depend not only upon the length of 
remaining intestine but also upon which type of 
intestine it is, jejunum, ileum or colon, and whether 
the remaining segment is proximal or distal. The
underlying problems created by the short intestine may
be further complicated by the superadded features of any 
continuing intestinal disorder, such as Crohn's disease 
or radiation enteritis.
The major features of the short bowel syndrome are
diarrhoea, malnutrition and weight loss. There may be
malabsorption of protein, carbohydrate and fat with 
consequent calorie depletion and steatorrhoea. There 
may also be debilitating fluid and electrolyte 
imbalances, and deficiencies of specific nutrients, 
minerals and vitamins.
Diarrhoea
The diarrhoea is often copious and, if steatorrhoea is a 
feature, malodourous. The rapid transit of food through
21
the shortened intestine allows the passage of unabsorbed 
sugars into the colon where the action of bacteria 
produces hydroxy-fatty acids. These exert a cathartic 
effect (18) as do bile acids which reach the colon in 
significant quantities if the terminal ileum has been 
resected (109,110,168). The result is the frequent and 
urgent passage of loose or frankly liquid stools often 
shortly after the ingestion of food, with painful skin 
excoriation particularly if the stool pH is acidic 
(206).
In some cases of Crohn's disease the colon may be 
severely affected and resection is necessary. The 
problems of diarrhoea in these patients are replaced by 
those of a high output small intestinal stoma, usually a 
jejunostomy. Without ileum or colon the capacity for 
water and sodium reabsorption is greatly diminished and 
there is a considerable risk of fluid and electrolyte 
depletion. Large quantities of sodium, calcium and 
magnesium may be lost from the intestine and the patient 
may suffer thirst, muscle cramps, hypotension and 
syncope from hyponatraemia, and tetany and carpopedal 
spasm from hypocalcaemia. Hypomagnesaemia may be 
manifest as muscle cramps, epileptiform seizures and 
calcium-resistant tetany. Potassium losses from the 
intestine are not a major problem but renal loss, in 
r e s ponse to h y p e r a l d o s t e r o n i s m  s e c o n d a r y  to
22
hyponatraemia, may be high leading to muscular weakness 
and irritability due to hypokalaemia.
The disability caused by diarrhoea or a high output 
stoma varies greatly among patients. At best, residual 
ileum and colon may keep diarrhoeal volume down to about 
1 litre daily, and further improvement can be gained by 
the use of antidiarrhoeal drugs such as codeine 
phosphate and loperamide (181). The effects of these 
agents appear to diminish as the length of remaining 
intestine decreases however, and the most severely 
affected patients derive no benefit from drug therapy 
and continue to lose several litres of stoma fluid 
daily.
Malnutrition and Weight Loss
Patients with troublesome diarrhoea or a high output 
stoma quickly learn that a reduced intake of food and 
fluid will give some respite from the need for frequent 
visits to the lavatory. If they yield to this 
temptation however, the reduction in nutrient intake 
merely compounds the problems of malabsorption and is 
followed by more rapid weight loss and malnutrition. 
Like the problems caused by diarrhoea there is a wide 
spectrum of severity of weight loss. In the most 
extreme cases this may be profound and rapid following
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copious fluid losses in the immediate postoperative 
period. If not adequately treated by parenteral 
replacement, these patients die of electrolyte 
imbalance. If this is avoided malabsorption of all 
major nutrients results in progressive malnutrition with 
loss of body fat and m u s c l e  mass. A l t h o u g h  
hypoproteinaemia may occur, it is seldom severe enough 
to cause oedema unless there is coexistent bowel 
disease. The outcome for these patients depends upon 
whether or not their remaining intestine can adapt 
sufficiently to improve absorption and allow them to 
regain their normal weight, or at least a stable state 
below their ideal weight. If insufficient bowel remains 
there will be progressive weight loss and eventual death 
from inanition, the fate of many of the survivors of 
'successful' surgery in earlier times (71,91,93,165,237) 
unless measures are taken to increase nutritional intake 
either by the oral route, or by the use of parenteral 
feeding.
Specific Deficiencies
In general, the severity of diarrhoea, malabsorption and 
malnutrition is approximately proportional to the length 
of small intestine remaining. When the terminal ileum 
is resected however, there may be considerable problems 
despite a reasonable length of proximal small bowel
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being present. This is because the terminal ileum is 
unique in having specialised sites for the absorption of 
vitamin B12 (22) and bile salts (29). A lack of vitamin 
B12 will result in pernicious anaemia and subacute 
combined degeneration of the spinal cord if allowed to 
persist. For this reason it has been recommended that 
intramuscular supplements should be given to all 
patients from whom 80-100cm of terminal ileum have been 
resected (86). The loss of the terminal ileum also 
interrupts the enterohepatic circulation of bile salts, 
leading to a reduction in the bile salt pool. Micelle 
formation is impaired with consequent reduction of fat 
absorption. When fat malabsorption is severe 
deficiencies of the fat soluble vitamins A, D and K may 
occur and supplements will be required. Deficiencies of 
the water soluble vitamins are rare until there is an 
extreme dearth of intestine.
Psychosocial
In common with many other chronic conditions the short 
bowel syndrome produces symptoms which reduce the 
wellbeing and physical activities of those afflicted. 
The depression of mood and deterioration of morale 
experienced by many patients is secondary not only to 
their physical problems, but is greatly increased by the 
social restrictions placed upon them. The persistent
25
need to open their bowel with the attendant threat of 
incontinence or leakage from a stoma appliance may be 
severe enough to restrict any activities outside the 
home. Family life is disrupted as eating becomes a
chore rather than a social event, holidays are 
impossible, and financial problems arise if the patient 
is the principal breadwinner.
26
PATHOPHYSIOLOGY
As indicated in the section on clinical features, the 
short b o w e l  s y n d r o m e  has a w i d e  v a r i e t y  of 
manifestations. To help describe the pathophysiology of 
the syndrome more clearly, it is advantageous to deal 
with the disturbances in gastric secretion and in the 
intestinal handling of water and electrolytes, minerals, 
and major nutrients separately, and to describe the 
changes which occur in the short bowel syndrome with 
reference to each nutrient.
GASTRIC ACID SECRETION
The majority of patients with the short bowel syndrome 
retain both the stomach, and all or part of the 
duodenum. This is due to the fact that in the diseases 
most commonly resulting in a short residual intestine, 
Crohn's disease and mesenteric vascular disease, the 
stomach and duodenum are infrequently affected. In 
Crohn's disease, gastroduodenal lesions are usually 
bypassed rather than being resected, and mesenteric 
vascular disease most commonly involves the superior 
mesenteric vessels which do not supply the stomach and 
duodenum.
Following bowel resection there is a period of gastric
27
hypersecretion which is well documented in the dog
(189.278) but which is a less consistent finding in man
(52.190.278). In the dog, this hypersecretion has been 
shown to be proportional to the length of small 
i n t e s t i n e  r e s e c t e d  (76,189) a l t h o u g h  t here is 
disagreement as to whether it is greater following 
resection of proximal (49,222) or distal, (189,212) 
segments of intestine. Experimental work has 
d e m o n s t r a t e d  a similar m a g n i t u d e  of g a s t r i c  
hypersecretion in dogs after antrectomy and vagotomy 
(133), to animals with an intact antrum, suggesting that 
the antrum is not a prerequisite for hypersecretion. 
Gastric function studies have shown no increased 
response to histamine (212,278) indicating normal 
parietal cell numbers and function. Gastrin is 
inactivated by the small intestine (252), loss of which 
might prolong the action of this hormone. This is a 
simpler explanation than the loss of an unidentified 
inhibitory agent normally produced by the small 
intestine, suggested by Windsor et al after the 
demonstration of a prolonged post-cibal acid response
(38.278).
H u m a n  studies have c o n f i r m e d  the p r e s e n c e  of 
hypersecretion in some patients following intestinal 
resection. Raised basal acid outputs have been 
demonstrated (178,278), but the response to exogenous
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stimuli such as pentagastrin is usually normal (178). 
Cimetidine has been used to reduce post-prandial 
hypersecretion (50,178) resulting in improved nutrient 
absorption by maintaining a more alkaline duodenal and 
jejunal pH (50). The role of gastrin remains under 
investigation; the majority of studies (50,178,276) have 
revealed normal levels in patients with a short 
intestine, but Straus et al (248) demonstrated elevated 
fasting and post-prandial gastrin levels and postulated 
the lack of a gastrin inhibitor, normally produced by 
the small bowel, to explain their findings in patients 
with massive resections.
In an extensive review of the problem of hypersecretion, 
Buxton (38) suggested that bacterial overgrowth might 
play a part by producing 'toxic' degradation products 
from dietary constituents and bile acids. These 
substances might then stimulate the production of a 
humoral agent in the intestinal mucosa resulting in acid 
hypersecretion and malabsorption. Although the exact 
mechanism of gastric hypersecretion remains unknown, it 
appears to be a transient phenomenon which may resolve 
in as little as two weeks after intestinal resection 
(278).
29
WATER AND ELECTROLYTES 
Jejunum
Current understanding of the mechanisms which govern 
water and electrolyte absorption in the small intestine 
is based upon the results of many in vitro and in vivo 
studies performed during the last twenty years. It has 
become clear that the jejunum and ileum, while similar 
in some respects, handle the majority of solutes in 
different ways (55,262).
There is now much evidence to support the concept that 
the majority of water movement across the intestinal 
mucosa takes place by way of intercellular channels 
(260) rather than through the cells themselves as 
previously thought (72). The movement of water is an 
entirely passive process in response to osmotic 
pressures exerted by solutes. Rapid movement of water 
leads to a secondary shift of some solutes by a process 
known as solvent drag (74) which is quantitatively more 
important in the jejunum where mucosal permeability is 
high than in the less permeable ileum.
It is likely that sodium absorption in the jejunum is a 
mainly passive process in response to electrochemical 
and concentration gradients, with solvent drag playing
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an important part secondary to water m o v e m e n t  
precipitated by the active absorption of glucose and 
amino acids. In addition there is probably an active 
transport mechanism for glucose and sodium absorption 
which depends on the presence of both substances for its 
satisfactory function (75,262). In contrast, potassium 
movement in the jejunum is entirely passive in response 
to concentration gradients and water flow (197,259,262).
Chloride absorption appears to be passive, but the 
handling of bicarbonate is rather different. It appears 
that bicarbonate can be absorbed against considerable 
concentration gradients down to a luminal concentration 
of 2-3 mmol/l (258). It is thought that this is 
mediated by the secretion of hydrogen ions which combine 
with bicarbonate to form water and carbon dioxide which 
then diffuse through the mucosa. The hydrogen ion 
secretion may be linked in a cation exchange with sodium 
thus explaining the observed phenomenon of bicarbonate- 
stimulated sodium absorption.
The details of the control mechanisims for jejunal 
absorption have yet to be elucidated. Although 
parasympathetic agonist and antagonist drugs (176), 
glucagon (101), secretin (100), cholecystokinin (64) and 
hydrocortisone (221) have been shown to affect the 
absorption of sodium, chloride and water, the doses used
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were pharmacological and a true physiological role for 
these substances in the control of jejunal absorption 
has yet to be defined.
In the normal state the jejunum has a more rapid transit 
rate than the ileum which appears to be regulated in 
part by the presence of fat in the terminal ileum (246). 
The ileocaecal valve in particular was thought to be 
important from a purely mechanical point of view, but it 
now appears that it is the presence of undigested fat in 
the terminal ileum and possibly also the caecum which 
exerts a slowing effect on the transit of chyme through 
the proximal small intestine. With the loss of the 
terminal ileum, the jejunum is unable to retain fluids 
and nutrients as efficiently as necessary, and chyme 
passes through a shortened bowel with considerable 
rapidity, causing copious diarrhoea and steatorrhoea 
with the risk of electrolyte disturbances. These 
features are particularly severe in patients who have 
required colectomy. This is especially true of 
electrolyte disturbances of which hyponatraemia is the 
most common. This results from the obligatory loss of 
small bowel chyme containing high concentrations of 
sodium. The loss of sodium leads to secondary 
hyperaldosteronism with consequent renal sodium 
retention and increased potassium loss in the urine. It 
is probably the high urinary potassium losses which lead
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to the hypokalaemia often seen in these patients, rather 
than excess loss from the small bowel.
Ileum
The ileal mucosa is less permeable to water and solutes 
than that of the jejunum leading to better retention of 
absorbed water than is possible in the proximal 
intestine. The reduced permeability also means that 
solvent drag is a less important mechanism for ion 
absorption than in the jejunum.
In vivo perfusion studies have demonstrated that there 
is active transport of sodium against considerable 
electrochemical gradients. It has been proposed that 
sodium absorption is linked with that of chloride which 
also demonstrates characteristics of an active transport 
system in contrast to its passive absorption in the 
jejunum. Turnberg et al (258) proposed a double ion 
exchange system to explain these active mechanisms which 
are associated with no electrical changes. Sodium is 
absorbed in exchange for hydrogen ions while chloride is 
exchanged for bicarbonate. The hydrogen and bicarbonate 
then form water and carbon dioxide which diffuse out of 
the intestine. Although there remains no direct proof 
of the existence of such a system, it accurately 
explains the experimental findings (262). The active
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absorption of sodium and chloride in the ileum results 
in greater absorption of these ions per unit length of 
intestine than in the jejunum (119).
Potassium absorption in the ileum remains a passive 
process in response to concentration gradients. 
Absorption appears to be increased when the luminal 
concentration of sodium is low, possibly due to changes 
in potential difference across the mucosa (259).
The normal ileum is relatively inaccesible for study, 
and experimental data obtained from perfusion studies 
must be extrapolated from the results obtained from a 
small segment to the whole organ. Patients with 
ileostomies present an interesting group for study, 
anatomically and functionally between the normal state 
and that seen in the short bowel syndrome.
The normal ileostomy produces about 500g of effluent in 
24 hours of which some 90% is water (102,139,241) Sodium 
concentration, normally 110-130 mmol/l (106,130,139,241) 
is lower than that found in the ileum of subjects with 
the colon in situ suggesting increased absorption by the 
ileum in these patients. The potassium concentration 
r e m a i n s  low, in the r a n g e  of 5-11 m m o l / l  
(106,130,139,241). The obligatory loss of sodium in 
quantities far higher than those found in normal stool
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means that patients with an ileostomy have an inherent 
risk of developing salt depletion and dehydration. This 
h a s  b e e n  r e p o r t e d  on s e v e r a l  o c c a s s i o n s  
(80,103,104,131,182) associated with low urine volume 
and sodium concentration but only a minor reduction in 
the sodium loss from the ileostomy. This persistence of 
sodium loss even in the face of dietary sodium 
deprivation has been comfirmed experimentally (140,177) 
although Clarke et al (43) reported one patient whose 
sodium loss from the ileostomy dropped to 62 mmol/l when 
dehydrated. In general however, dietary sodium 
d e p r ivation, although leading to s e c o n d a r y  
hyperaldosteronism is usually attended by only minor 
reductions in sodium loss from the ileostomy. Potassium 
losses may rise significantly to levels of 20-30 mmol/l 
(140,177) although the mechanism for this finding is 
unknown. Chronic depletion of total body water, 
exchangeable sodium and potassium has been reported in 
seemingly healthy ileostomists (44,103,261). In one 
series (261) the deple t i o n  a p p e a r e d  to be an 
intracellular phenomenon associated with normal plasma 
electrolytes and, in some cases, normal aldosterone 
levels. Newton et al (182) sampled the urine of 
patients with ileostomies and on the basis of low sodium 
concentrations of less than 10mmol/l defined a group 
requiring sodium repletion. These patients had raised 
aldosterone and renin levels which returned to normal
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after oral rehydration and salt replacement. Kennedy et 
al (131) compared a group of ileostomists with matched 
controls. As a group, the ileostomists had raised 
aldosterone levels with low urinary sodium and raised 
urinary potassium losses. The findings from these 
different studies suggest that although there is a 
satisfactory aldosterone response to salt depletion in 
these patients the ileum appears to be unable to respond 
as effectively to this hormone as does the colon 
(148,149). This is confirmed by the demonstration that 
the administration of exogenous aldosterone and 9-alpha- 
fluorohydrocortisone does not alter the losses of sodium 
or water from ileostomies (84,141,149).
Colon
Under normal conditions the human colon functions as a 
salvage mechanism, principally to absorb water and 
electrolytes, thus converting liquid ileal chyme to 
solid stool. The colon receives 1000-1500ml of small 
intestinal content over a 24 hour period (198,211) 
containing electrolytes at concentrations similar to 
those found in plasma (59,198). The efficiency of the 
colon is such that it will absorb 95-99% of the sodium, 
chloride and water, and 50% of the potassium presented 
to it (198).
36
Sodium absorption is the most important colonic function 
because it affects the absorption of other electrolytes 
and water. There is an active transport mechanism which 
is not glucose-dependent (257) in contrast to that found 
in the small intestine (59). Sodium is 'pumped' out of 
mucosal cells across the basolateral membrane creating a 
concentration gradient down which sodium is absorbed. 
The pump creates a potential difference which 
facilitates the absorption of chloride against a 
concentration gradient (59,257), and the secretion of 
potassium (62). Water absorption is an entirely passive 
consequence of solute movement (62,257). Although 
bicarbonate can be absorbed by the colon (62), secretion 
is promoted by the presence of chloride in the lumen. 
It is likely that an anion exchange occurs (59,62,257) 
similar to the mechanism demonstrated in the ileum 
(258). The colon also differs from small intestine in 
its ability to increase the absorption of sodium, 
chloride and water in response to aldosterone (148).
Diarrhoea results from the colon being unable to cope 
with the demands of absorption placed upon it. This may 
occur in several ways relevant to patients with small 
bowel resection. Perfusion experiments have shown that 
the colon can absorb up to 5.7 litres of water in 
24 hours (61), an estimate which correlated well with 
clinical studies of Asiatic cholera (16) and pancreatic
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diarrhoea (208). This functional reserve is however, 
vulnerable to sudden fluctuations in the rate of 
delivery of fluid into the caecum. Diarrhoea results if 
500ml of ileal-like fluid is instilled into the colon in 
one hour, a flow rate of 8.3ml/minute (61) and occurs 
with increasing frequency at higher flow rates (192). 
When a short intestine and rapid transit are present, a 
large bolus of fluid and food may enter the colon 
shortly after ingestion and precipitate diarrhoea.
Such a bolus may contain larger quantities of 
carbohydrate, fat and bile acids than normal ileal 
fluid. The excess carbohydrate exerts an osmotic effect 
in the colon with subsequent diarrhoea (54). Larger 
amounts of short chain fatty acids will be produced, but 
because they are very rapidly absorbed, it is unlikely 
that they contribute significantly to the osmotic 
disturbances (54).
Long chain fatty acids appear to have a greater part to 
play in the diarrhoea associated with steatorrhoea. 
Intestinal motility is increased (18) and they are 
metabolized to hydroxy-fatty acids by bacterial action. 
Hydroxy-fatty acids decrease sodium and water 
absorption by the colon and may thus contribute to 
diarrhoea (8). In some cases the substitution of medium 
chain triglycerides in the diet has been successful in
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reducing the concentration of hydroxy-fatty acids and 
the volume of diarrhoea (244).
Bile acids are normally absorbed in the distal ileum 
(29) and enter the colon only in small quantities. 
After ileal resection faecal losses may be considerably 
increased (89,110) with important consequences. Bile 
acids reduce the absorption of, and in some cases 
promote secretion of sodium, chloride and water 
(168). In ileal resections of less than 100cm this is 
the most important cause of diarrhoea, as only minor 
steatorrhoea occurs (110). Longer ileal resections 
result in increased losses of bile acids which cannot be 
compensated for by increased synthesis (5,109). Jejunal 
bile acid concentration falls, and steatorrhoea becomes 
a major factor in the diarrhoea. It has been suggested 
that both hydroxy- and non-hydroxy-fatty acids 
contribute as the diarrhoea can be reduced by the use of 
medium chain 'triglycerides (110).
MINERALS
Calcium
Calcium is absorbed throughout the small intestine, the 
ileum being quantitatively more important although the
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rate of absorption is faster in the jejunum (55). 
Absorption is regulated by the active metabolite of 
vitamin D, 1,25-dihydroxycholecalciferol. This is 
p r o d u c e d  by tw o  separate h y d r o x y l a t i o n s  of 
cholecalcif erol, vitamin D3, the first, at the 25 
position, occurring in the liver, and the second at the 
1 position being completed in the kidneys. A second 
metabolite, 24, 25-dihydroxycholecalciferol is produced 
in the kidneys, but its exact metabolic role has yet to 
be fully defined (55,66).
I
Under the influence of 1,25-dihydroxycholecalciferol, 
calcium binding protein is secreted into the intestinal 
lumen where it takes up calcium. The complex is then 
absorbed. Calcium absorption is an active process at 
luminal concentrations of l-5mmol/l and can occur 
against concentration and electrical gradients in the 
absence of water movement (117). At higher luminal 
concentrations, the active transport tends to become 
saturated and passive absorption occurs (55,117,194).
The complex nature of calcium absorption means that it 
can be disrupted in a number of ways. Reduction of the 
active absorption occurs when there are low levels of 
1,25-dihydroxycholecalciferol as is found in patients 
with chronic renal failure, although the passive 
component of absorption remains normal (117). Low
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levels of 1,25-dihydroxycholecalciferol may also result 
from malabsorption of vitamin D after small bowel 
resection (47,60), and in coeliac disease and 
pancreatic steatorrhoea (253).
When normal vitamin D levels are present calcium 
malabsorption may still occur because of inadequate 
dietary intake, or because of interference by other 
dietary constituents such as phytates, phosphates, 
oxalates and fatty acids (3,55). Much has been written 
about the effects of fat on calcium absorption, and the 
concensus has been that high quantities of dietary fat 
restrict calcium absorption. Agnew et al (3) studied 
patients after partial gastrectomy, normal subjects, and 
patients with malabsorption, and observed the effects of 
adding either long or medium chain triglycerides to a 
standard meal. The long chain t r i g l y c e r i d e s  
significantly depressed calcium absorption compared with 
medium chain triglycerides and compared with diets 
containing no added fat in the group as a whole, but 
these effects were not evident in the patients with 
malabsorption. Patients with steatorrhoea of greater 
than lOg faecal fat daily had significantly reduced 
calcium absorption compared with normals regardless of 
what type of fat was used as a supplement.
Calcium absorption is said to be reduced by fat because
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of the production of calcium soaps by saponification 
with fatty acids. In experiments with rats, absorption 
of calcium from such soaps has been shown to be related 
to the fatty acid length, being least from long chain 
soaps, particularly when these contain saturated fatty 
acids (79). However, w h e n  fat was given as 
triglycerides along with calcium rather than as soaps 
produced in vitro, there was negligible formation of 
soaps in the intestine and no effect on calcium 
absorption.
Magnesium
Since the first reports of magnesium deficiency in man 
(15,26,70,88,155) there has been debate over the precise 
mechanism of its absorption, and extensive reviews of 
the literature pertaining to its absorption and roles in 
metabolism have been produced (10,251,267,268,269). 
Some of the apparent disagreement in experimental 
results may have arisen because of the study of several 
different species, a point raised by Brannan and her 
colleagues (33) who studied the jejunal and ileal 
absorption of magnesium from magnesium chloride using an 
in vivo perfusion method in human subjects. They 
demonstrated that magnesium absorption is active in both 
jejunum and ileum and that the mechanism tends to become 
saturated at a luminal magnesium concentration of
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10mmol/l. Increasing luminal calcium concentration had 
no effect on magnesium absorption. In patients with 
chronic renal disease, magnesium absorption was 
significantly reduced possibly as a result of reduced 
levels of 1,25 dihydroxycholecalciferol. Hydroxylated 
metabolites of vitamin D have been used to increase the 
plasma magnesium levels of patients with a short 
intestine, but normal levels were achieved only with the 
use of magnesium supplements (229). Magnesium 
absorption therefore appears to be an active process 
independent of calcium but needing vitamin D for maximal 
activity. There may also be superimposed passive 
diffusion which becomes important only at higher luminal 
concentrations (55).
Magnesium depletion and deficiency is likely to develop 
in p a t i e n t s  w h o  lose l a r g e  q u a n t i t i e s  of 
gastrointestinal content as a result of malabsorption, 
bowel resection, fistulous drainage, or prolonged 
nasogastric aspiration (268). Booth et al (26) reported 
hypomagnesaemia in 15 of 42 patients with malabsorption 
of various causes. In one patient with intestinal 
resection, magnesium loss was increased by a high fat 
diet of 138g/day but a positive balance was attained 
without magnesium supplements on a diet containing only 
32g fat daily suggesting that magnesium is lost as 
insoluble soaps in steatorrhoea. However, a second
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patient, also with small bowel resection, failed to 
maintain a positive magnesium balance on a low fat diet 
and required oral supplements.
Zinc
Zinc is one of the most important trace elements in the 
human diet. It is essential for the function of many 
enzyme systems (214) and deficiency has wide-ranging 
consequences. These include growth retardation, 
anorexia and disorders of taste, hypogonadism, impaired 
wound healing and cellular immunity, and a dermatitis 
which resembles acrodermatitis enteropathica, a 
genetically determined disorder of zinc absorption. 
(151,162,263)
Zinc is absorbed in the small intestine, although the 
exact site and mechanism is unclear (9). Normally, 
small quantities are excreted in the faeces, but in 
diarrhoeal diseases stool losses increase significantly 
(280). The losses are greatest when the entire intestine 
is present, and the zinc concentration is lower in fluid 
from high stomas or fistulae. Malabsorption of zinc 
exacerbates these excess losses, particularly if there 
is active inflammatory bowel disease (151,249). Oral 
supplements of zinc sulphate may be successful in mild 
cases, but patients needing intravenous feeding will
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need parenteral zinc (280). The quantities required 
vary considerably depending on gastrointestinal losses 
but in general, a supplement of 3-12mg (50-200micromol) 
appears satisfactory in most cases needing parenteral 
nutrition (162,280).
VITAMINS
The majority of vitamins can be absorbed throughout the 
small intestine and depend upon the satisfactory 
transport of water or lipids for their own absorption. 
The exception is vitamin B12 which is selectively 
absorbed from the terminal ileum (22) in association 
with gastric intrinsic factor. Absorption is invariably 
abnormal if 6 feet or more of terminal ileum has been 
resected (22) and lifelong intramuscular supplements 
will be required.
Water soluble vitamins and folic acid are rapidly 
absorbed in the jejunum. Active transport systems have 
been identified for ascorbic and folic acid, and 
possibly exist for thiamine and riboflavine while 
pyridoxine is absorbed by diffusion. The method of 
absorption for nicotinamide, pantothenic acid and biotin 
remains unknown (112). The reserve capacity of the 
jejunum is so great that even when large doses of
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pyridoxine were given to normal subjects, only small 
amounts reached the ileum, and absorption was 
essentially normal even in patients who retained between 
4 and 8 feet of jejunum and no ileum. (32). Booth et al 
(23) found that absorption of folic acid was normal 
after resection of all but 3-4 feet of jejunum, and that 
it became abnormal only when as little as 8 inches of 
jejunum remained. It seems likely that patients able to 
maintain a satisfactory nutritional state without 
parenteral nutrients should be able to absorb sufficient 
quantities of water soluble vitamins from a normal diet.
The fat soluble vitamins A,D,E and K are absorbed after 
micelle formation in the small intestine. The proximal 
jejunum is the principal site of fat absorption (28) 
although the ileum becomes more important at higher 
dietary intakes (25). Malabsorption of vitamins is 
likely when steatorrhoea is present regardless of the 
underlying disease and has been documented for vitamin D 
in coeliac disease and pancreatic disorders (254). 
Although jejunal resection can be compensated for by 
increased ileal absorption, terminal ileal resection 
interupts the enterohepatic circulation of bile salts, 
and possibly of 25 hydroxycholecalciferol itself. Thus 
malabsorption of vitamin D may be present when as much 
as 390cm of proximal small intestine remain (47). The 
absorption of vitamins A,E and K has received less study
46
although vitamin A absorption has been used as an 
indicator of fat absorption (6). It is likely that 
malabsorption similar to that of vitamin D will occur in 
steatorrhoea, and that a patient's vitamin K supply is 
further diminished by colectomy and the consequent 
removal of the bacterial source of this vitamin 
(17,175).
ABSORPTION OF MAJOR NUTRIENTS 
Protein
In man the assimilation of protein is normally an 
extremely efficient process, for of 70-100g exogenous 
and 30-200g endogenous protein presented to the 
intestine each day only 6-12g (l-2gN) appear in the 
faeces (78). Dietary protein is initially digested by 
gastric proteases producing mainly polypeptides, some 
oligopeptides (2-6 amino acid residues), and a few free 
amino acids. After the actions of the several 
pancreatic aminopeptidases, large quantities of 
oligopeptides and free amino acids are present in the 
intestinal lumen (78). It has been suggested that the 
final stage in peptide digestion occurs in the mucosal 
brush border where free amino acids are progressively 
cleaved from oligopeptides to produce tri- and
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dipeptides (78,167).
The mechanisms whereby the products of digestion are 
absorbed into the bloodstream have been the subject of 
much investigation which has been extensively reviewed 
over the past ten years (77,78,167,235,240). It is now 
known that free amino acids and peptides are absorbed by 
different active transport systems (167) and that amino 
acids are more rapidly absorbed when present as di- and 
tripeptides than as the free form (2,167,231,233). Amino 
acids are absorbed from peptides in two main ways (2): 
first, the peptide may be transported intact into 
mucosal cells where it undergoes hydrolysis, which 
appears to be the predominant mechanism in the jejunum. 
Second, the peptide may undergo hydrolysis in the 
mucosal brush border with transport of the free amino 
acids (235). This is the predominant mechanism in the 
ileum (78,167). These two systems appear to be equally 
effective as peptide absorption rates in the jejunum and 
ileum are similar (2,235). Although free amino acids 
are more rapidly absorbed in the jejunum than in the 
ileum (1,234), the small bowel has a greater absorptive 
capacity for mixtures of oligopeptides and amino acids 
than for free amino acids alone (232,233).
Borgstrom et al (28) suggested that digestion and 
absorption is almost completed in the jejunum, a theory
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supported by Nixon and Mawer (183) who claimed that 
maximal absorption took place in the duodenum and 
proximal jejunum. Using a multiple-lumen tube for small 
intestinal perfusion studies, Chung et al (42) have 
shown that while 60-65% of ingested protein in the form 
of bovine serum albumin is digested and absorbed in the 
proximal 150cm of the small intestine, the remainder is 
efficiently absorbed in the ileum, only 1-2% appearing 
at a collecting site 300cm distal to the duodenal- 
jejunal junction. This suggests that while 150cm of 
small bowel remains, about two thirds of ingested 
protein will be absorbed.
Patients with a short residual intestine lose greater 
quantities of nitrogen in their faeces or stoma effluent 
than normal. The losses have been reported to be in the 
order of 2.8 - 6.6gN/day (27) and 2.1-5.2gN/day (115). 
The higher losses suggested that a higher dietary input 
was necessary to maintain positive nitrogen balance. 
Althausen (6) however, had previously demonstrated that 
positive nitrogen balance could be maintained in a 
patient with resection of all but 45cm jejunum 
anastomosed to mid-transverse colon, on an intake of 
only 10.3gN daily (65g protein). The faecal nitrogen in 
this patient was never more than 3.9g/day.
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More recently, Ladefoged and her colleagues (144) 
studied patients retaining between 30cm and 200cm small 
intestine and demonstrated a wide range for nitrogen 
absorption from 21% to 66% of dietary intake. In 
patients who had undergone a resection of greater than 
150cm small bowel, Hylander et al (115) found absorption 
of 43% to 83% of ingested nitrogen compared with the 
normal range of 80-90% (28). These findings suggest 
that some patients with a short intestine will need a 
higher protein intake than normal, but that others may 
manage well with no increase.
Carbohydrate
In Western society, dietary carbohydrate is composed 
mainly of starch with smaller quantities of sucrose, 
lactose and fructose. Digestion takes place in a series 
of steps as food travels down the gastrointestinal 
tract. Initially, salivary amylase acts on the alpha 
1,4 linkages of starch until inactivated by gastric 
acid. In the duodenum, pancreatic amylase continues the 
process producing oligosaccharides and branched 
dextrins. The final step takes place in the mucosal 
brush border where sucrase, maltase, isomaltase and 
lactase produce the monosaccharides glucose, galactose 
and fructose (56,209).
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Glucose and galactose are absorbed by a carrier-mediated 
transport system distinct from that responsible for 
fructose absorption (111). It is responsible for 80% of 
glucose absorption and its efficiency is increased in 
the presence of sodium (209). Fructose absorption is 
slower, and occurs down its concentration gradient by 
facilitated diffusion. Glucose absorption proceeds 
rapidly in the small intestine and is completed in the 
proximal 100cm of jejunum (28). Such is the absorptive 
capacity of the jejunum that Booth (23) found no 
abnormality of glucose tolerance until only a few inches 
of jejunum remained. When the jejunum has been resected 
the ileum is capable of glucose absorption although 
oligosaccharide hydrolysis is slower (85). When 
unabsorbed carbohydrate reaches the colon, some attempt 
at 'colonic salvage' will occur as bacteria metabolise 
glucose to produce short chain fatty acids which are 
absorbed by the colon (20,215).
Fat
The absorption of dietary fat is perhaps the most 
complex of the processes responsible for the absorption 
of the three major nutrient groups, involving the 
secretions of several organ systems for its successful 
conclusion (82). The majority of dietary fat is in the 
form of long chain triglycerides which are subjected to
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minor digestion by lingual and gastric lipases before 
reaching the duodenum. Pancreatic lipase is the most 
important enzyme involved in fat digestion and its 
action, in conjunction with pancreatic colipase, 
produces a mixture of free fatty acids and 2- 
monoglycerides. Fat absorption is a passive process 
which relies on the solubility of fatty acids and 
monoglycerides in the lipid cell membrane. To reach the 
membrane however, dietary fat must first traverse the 
unstirred water layer, estimated to be 600 microns in 
depth (210), coating the mucosa. This is achieved by 
the emulsification of fats by bile salts to form 
micelles, and will only occur when the bile salts are 
present in their critical micellar concentration. This 
has been estimated to be 0.25 mmol/l (58). Micelles 
disintegrate at the cell membrane, fatty acids and 
monoglycerides being absorbed, and bile salts proceeding 
down the intestine to the terminal ileum where they are 
reabsorbed. It has been estimated that the entire bile 
salt pool circulates through the intestine four or five 
times during the digestion and absorption of a fatty 
meal (30). As discussed in the section on the colon, 
resection of the terminal ileum leads to excessive 
faecal losses of bile salts, reduction of the bile salt 
pool, and in some cases to an inability to attain the 
c r i t i c a l  m i c e l l a r  c o n c e n t r a t i o n  r e s u l t i n g  in 
steatorrhoea. In the mucosal cell triglycerides are
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r e f o r m e d  from the a b s o r b e d  fatty a c ids and 
monoglycerides, and leave the cell with phospholipids, 
cholesterol and proteins as chylomicrons. Medium chain 
triglygerides are subject to the above digestion and 
absorption processes but can also be absorbed without 
the need for predigestion. They differ from long chain 
triglycerides in that they are absorbed directly into 
the portal blood stream rather than being transported in 
the lymph. Although they form no part of the normal 
diet, they can be s u b s t i t u t e d  for long c h a i n  
triglycerides in conditions which reduce the ability to 
digest or absorb normal fats. Their use in the short 
bowel syndrome is however open to debate*
The whole small intestine is capable of fat absorption. 
When corn oil was used as the fat source, 90-95% was 
absorbed in the proximal 100cm of jejunum (28). Booth 
et al (24) subsequently demonstrated that the ileum 
plays an increasingly important part in fat absorption 
as dietary fat levels increase between 30g and 150g 
daily. The intact small intestine appears to be capable 
of absorbing almost unlimited quantities of fat. 
Masterton et al (166) studied two polar explorers who 
were able to absorb 263g and 276g respectively from 
diets containing 273g and 285g. Patients with bowel 
resection however, may have steatorrhoea at more modest 
intakes. Booth (24) found that resection of up to 8
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feet of terminal ileum did not result in increased 
faecal fat levels when dietary fat intake was less than 
64g daily but that increasing lengths of resection 
resulted in increased faecal fat losses at lower 
intakes.
In addition to electrolytes the colon has been shown to 
absorb short chain fatty acids (160,215). Carbohydrate 
in the colon undergoes anaerobic metabolism to acetic, 
propionic and butyric acids (20) which are then rapidly 
absorbed with secondary water absorption (54). It has 
been calculated that over 500kcal daily could be 
absorbed in this way (215).
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MANAGEMENT OF THE SHORT BOWEL SYNDROME
The general aim of management for all patients with a 
short intestine must be not only to make maximum use of 
the residual intestine, but to do so using a combination 
of electrolyte replacement, dietary manipulation and 
supplementation, drug therapy and parenteral nutrients 
which is acceptable to the individual and reduces, 
rather than increases, the existing symptoms and 
restrictions.
FLUID AND ELECTROLYTE REPLACEMENT
The majority of our knowledge of the usefulness of oral 
electrolyte replacement mixtures has come from work done 
in developing countries. Large numbers of patients 
suffering from acute diarrhoeal conditions caused by 
Vibrio cholerae, enterotoxigenic Escherichia Coli and 
rotavirus have been treated with considerable success 
using sugar - electrolyte mixtures (199,200,220). These 
clinical reports have been complemented by the results 
of jejunal intubation experiments which have yielded 
much information about saccharide and electrolyte 
absorption.
In normal human volunteers, fluids entering the jejunum
J
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acquire a similar sodium concentration and tonicity to 
plasma by equilibration with intestinal secretions 
(73,197). This suggests that an 'ideal solution' should 
have a sodium concentration close to that of plasma or 
greater, while remaining approximately isotonic when 
other ions and sugars are taken into account.
If solutions of sodium chloride are instilled into the 
jejunum, little absorption occurs (74,239). However, the 
absorption of sodium bicarbonate is better, suggesting 
that there is a transport mechanism for bicarbonate 
wh i c h  s t i m u l a t e s  s o d i u m  a b s o r p t i o n  (239,258). 
Bicarbonate absorption is best at luminal concentrations 
greater than that of plasma, and equilibration in the 
ileum is reached at a luminal concentration of about 
40mmol/l (199). For these reasons, and also to combat 
the acidosis which may occur after colectomy, there is a 
theoretical need for bicarbonate in oral electrolyte 
replacement solutions. This has however been challenged 
by Fordtran (75) who has demonstrated that sodium 
absorption is best from glucose-electrolyte mixtures 
when chloride is the only anion present.
The solution r e c o m m e n d e d  by the W o r l d  H e a l t h  
Organisation for use in acute diarrhoeal diseases sought 
to combat the problems of dehydration, hyponatraemia, 
hypokalaemia and acidosis by incorporating sodium
56
QOminol, potassium 20mmol, chloride 80mmol, bicarbonate 
30mmol and 20grams glucose in 1 litre of water (200) 
This solution has been instrumental in reducing the 
mortality incurred by patients with severe diarrhoea 
(12,207), and has been effective in avoiding the use of 
intravenous fluid replacement, with its attendant 
complications, in the majority of patients (40).
Since Schedl and Clifton (224) showed that glucose, 
sodium and water absorption are linked, the need for a 
sugar in electrolyte replacement mixtures has not been 
disputed. Solutions c o n t a i n i n g  m a n y  d i f f e r e n t  
concentrations of glucose have been tested in an attempt 
to find the optimal concentration. In perfusion studies, 
maximal sodium and water absorption occurred when 
between 56 and 85mmol glucose per litre was used (239). 
In cholera patients 160mmol/l has been shown to be 
superior to 40mmol/l (199). This has been supported by 
Nalin et al who recommend a 2% glucose solution 
(110mmol/l) after extensive experience in the treatment 
of diarrhoeal diseases.
There has been debate as to which saccharide source is 
best to promote sodium and water absorption. Several 
studies have been undertaken using glucose as the 
standard against which all other carbohydrates must be 
judged. These have shown that sucrose (193,220,250) and
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rice-powder (174) can be effective in promoting sodium 
and water absorption in patients with severe diarrhoea. 
Theoretically, the disaccharide maltose should be 
suitable for inclusion in oral electrolyte replacment 
mixtures as glucose is better absorbed from maltose than 
from solutions of free glucose itself (127,159). The 
use of a disaccharide also allows an increase in the 
sodium content without increasing the final osmolality 
of the mixture.
Experience with electrolyte replacement solutions in the 
short bowel syndrome is limited, glucose-containing 
mixtures being used with success in some cases (53), but 
not in others (81). In less extreme cases, glucose 
electrolyte mixtures have been given successfully to 
ileostomy patients who had a large stoma output to 
reverse dehydration and hyponatraemia (182,271). Griffin 
et al (87) used a mixture containing glucose polymer as 
a carbohydrate source to avoid parenteral fluid 
replacement in two patients with short residual 
intestine measuring 75cm and 25cm respectively. The 
latter patient retained most of the colon in addition to 
the short length of small bowel. The solution described 
by them has been successfully used in another patient 
who retained 125cm small intestine (147).
Although the majority of patients with an ileostomy have
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a low output of less than 500g daily which correlates 
well with body weight (105), ileostomists with a high 
daily output (defined as more than lOOOg) may benefit 
from treatment with codeine phosphate or loperamide to 
reduce the volume of effluent and the daily sodium 
losses (136). Newton (181) demonstrated that both 
codeine, and to a lesser extent Lomotil (diphenoxylate 
and atropine) reduced sodium and water loss from an 
ileostomy, but that Isogel (ispaghula husk), although 
improving effluent consistency, actually increased the 
losses of sodium.
DIETARY MANIPULATION
The theory behind current practices in dietary 
manipulation in the short bowel syndrome is based on 
the knowledge of the different absorptive functions of 
different parts of the small bowel. The work of 
Borgstrom et al (28) with normal subjects and Althausen 
et al (6,7), and subsequently Booth et al (23,25,27) 
with patients who had varying lengths of small bowel 
remaining, laid the foundations of present knowledge 
about nutrient digestion and absortion.
The common findings that fat, protein and calories were 
lost in greater quantities in the faeces than was normal
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prompted the conclusion that in such patients, the diet 
should contain larger quantities of protein, more 
calories and smaller amounts of fat than usual (27). In 
short bowel cases, it has been common practice to 
restrict dietary fat intake for a number of reasons. A 
high fat intake was held to predispose to higher faecal 
output, with an increase in diarrhoea and higher losses 
of calcium and magnesium with the risk of bone 
decalcification, tetany and convulsions. Increased 
protein was advocated because of increased faecal 
losses, and also to provide a calorie source with extra 
carbohydrate in place of the restricted fat. This 
regimen has become the traditional staple of many who 
treat patients with a short intestine (86,107,142, 172).
Booth et al (23,25) subjected patients with bowel 
resections to variations in their dietary fat and 
studied the effects on calcium balance. In one case, 
diets containing 38g and 62g fat daily were compared. 
Although a positive calcium balance was attained on the 
lower fat diet on some occasions, this was not always 
accompanied by a low faecal fat loss. In another study 
in the same patient, the calcium balance was negative 
despite a low faecal fat loss. The most significant 
gain in calcium balance was seen following parenteral 
administration of vitamin D. In other patients, 
diarrhoea and tetany did follow a higher fat diet, but
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the restriction required to regain control of bowel 
habit was never less that 40g fat daily. In one patient, 
magnesium losses were increased by a high fat diet of 
138g/day and a positive balance was attained without 
magnesium supplements on a diet containing only 32g fat 
daily. However a second patient, also with small bowel 
resection, failed to maintain a positive magnesium 
balance on a low fat diet and required oral supplements. 
Support for the concept that a diet containing large 
amounts of fat is detrimental has been forthcoming from 
studies which showed reduction of steattorrhoea and 
diarrhoea when medium chain triglyceride were 
substituted in the diet (19,201,286). The effect on 
faecal nitrogen loss and weight gain was, however, more 
variable.
By contrast, patients have been shown to thrive without 
recourse to a low fat diet. Schwartz et al (227) 
commented on the constant percentage of dietary fat and 
nitrogen lost in the stool on diets of different 
composition, and found that merely increasing nitrogen 
and total calorie intake was sufficient to promote 
weight gain and good health. More recently the necessity 
of a low fat diet has been strongly challenged 
(236,281).
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Simko et al (236) have stated that a high fat diet of 
200g daily can be beneficial following studies in a 
single patient with only 137cm jejunum remaining and a 
terminal jejunostomy. He found that stoma effluent 
volume decreased as did the losses of bile acids on the 
high fat diet compared with one which contained 64g fat 
daily. Woolf et al (281) approached the problem by 
keeping dietary protein, fibre, fluid and mineral input 
constant and varying fat and carbohydrate only. They fed 
both diets, containing 40g and 120g fat respectively to 
8 patients with short lengths of residual intestine. In 
a cross-over study they demonstrated no difference in 
the faecal dry weight or in the losses of water, 
calcium, magnesium or zinc between the two diets. This 
result was in accord with Bochenek et al (19) who had 
shown no benefit from the use of a diet containing 50g 
fat daily.
Most authors have stressed the fact that as dietary fat 
increases, the faecal fat increases in a linear manner 
(23,25,227). Few have emphasised the fact that the 
percentage of fat absorbed remains remarkably constant 
at about 60-65% of intake on diets containing varying 
quantities of fat (227). This means that patients may 
have a higher calorie intake on a higher fat diet and if 
there is no detrimental effect on stool volume and 
consistency, they may benefit from a more liberal
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attitude to the quantity of fat that they are allowed in 
their diet.
Patients who develop low levels of vitamin D or 
hypocalcaemia may respond to oral supplements. Daily 
doses of 4000-12000iu have been recommended for patients 
with steatorrhoea (238) but excellent clinical results 
and r e v e r s a l  of a b n o r m a l  l e v e l s  of 25- 
hydroxycholecalciferol have been achieved using only 
900iu calciferol daily in patients with intestinal 
resection and steatorrhoea (60). If oral treatment is 
ineffective, parenteral treatment with an hydroxylated 
metabolite of vitamin D is justified (66).
The treatment of magnesium depletion in the acute stage 
is straightforward, using intravenous or intramuscular 
magnesium sulphate in a dose of 1.5ml of 10% sol. (157). 
Oral supplementation of the diet of patients at risk is 
more difficult because of the cathartic action of some 
magnesium salts (269). Booth et al (26) recommended the 
use of magnesium chloride 0.25mmol/kg/day in patients 
with malabsorption, and Hessov et al (96) reported the 
use of 22mmol of the same salt daily for three months 
succesfully to reverse magnesium depletion in patients 
after small intestinal bypass procedures for obesity. 
Magnesium hydroxide 30mmol/day was used to improve the 
mental and physical state of one patient with massive
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small intestinal resection (70), although 23mmol/day was 
unsuccessful and intramuscular magnesium sulphate was 
needed to reverse depletion in a similar patient (188). 
Magnesium oxide has recently been used in a dose of 15- 
20mmol daily to reverse symptomatic hypomagnesaemia in a 
group of seven patients with small intestinal resections 
(229).
LIQUID DIETARY SUPPLEMENTS
Liquid dietary supplements are used in many clinical 
situations other than the short bowel syndrome. They 
may be classified in two main categories, namely 
elemental, chemically - defined or defined - formula 
diets, and non-elemental, whole protein or polymeric 
diets. Chemically-defined diets were initially produced 
as a low-residue feed for space flight (279), and 
consisted of a mixture of protein as amino acids, and an 
energy source mainly as carbohydrate presented as mono- 
or oligosaccharides supplemented with minerals and 
vitamins. Little fat was included in the early 
formulations, of which Vivonex (Eaton Laboratories) is 
the best known example. The combination of free amino 
acids and oligo- and monosaccharides in large quantities 
resulted in a high osmolality which has been blamed for 
many of the side effects of these preparations.
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To combat the problems of high osmolality, and in the 
light of reports (2,51,231,232,233) showing that short 
peptides were absorbed as well as, or better than free 
amino acids, newer chemically-defined diets contain 
nitrogen as mixtures of amino acids and short peptides 
(2-6 amino acids), carbohydrate as oligosaccharides and 
less free glucose, and more fat, often utilising medium- 
chain triglycerides (8 to 10 carbon atoms). These newer 
preparations,, such as Nutranel (Roussel), which was used 
in the experimental work in this thesis, also have a 
higher nitrogen: calorie ratio, which may be important in 
maintaining positive nitrogen balance. All elemental 
diets have tended to have a low electrolyte content, 
with added minerals and vitamins.
Non-elemental, or polymeric diets have developed from 
whole food homogenates designed and formulated by 
hospital diet kitchens, often with additions of high 
protein and high calorie food supplements. In recent 
years the number of proprietary polymeric diets has 
increased enormously, reflecting the new emphasis being 
placed on enteral nutrition in patients suffering from a 
wide variety of conditions. Most proprietary feeds 
obtain their protein from hydrolysates of casein, soy 
protein isolate, or a combination of both. Both fat and 
c a r b o h y d r a t e  are us e d  as energy sources, the 
carbohydrate mainly as polysaccharides with some
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oligosaccharides, and the fat from vegetable sources 
such as maize oil and mainly long-chain triglycerides. 
The osmolalities of such feeds are usually lower than 
those of chemically-defined diets and the electrolyte 
content is higher. Vitamin supplements are added as in 
the elemental diets. Commonly used polymeric diets 
include Clinifeed (Roussel), Nutrauxil (Kabivitrum), 
Isocal (Mead Johnston), and the preparation used in the 
experimental work in this thesis. Ensure (Ross Abbott). 
Many of the polymeric diets now contain no lactose to 
avoid the possible problem of diarrhoea in patients who 
are lactase deficient.
The rationale governing the use of chemically-defined 
diets is that they require little or no digestion and 
can be absorbed through the bowel wall in the form in 
which they are ingested. They are thus recommended 
"when digestion or absorption is impaired as in 
malabsorption states, the short bowel syndrome and as 
treatment following total gastrectomy" and "may be used 
in the preparation of the bowel prior to diagnostic 
procedures" (Vivonex data sheet). This latter 
recommendation is based upon the fact that the 
chemically-defined diets contain little residue and are 
said to promote small volume stools.
Polymeric diets are recommended for use as nutritional
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supplements in any situation where the patients food 
intake is inadequate, and particularly when nasogastric 
tube feeding is required. Suggested indications include 
"semi-consciousness or coma, illness where anorexia 
limits food intake, conditions affecting the swallowing 
muscles, oral pathology and preoperative preparation and 
postoperative care" (Ensure data sheet).
Historically, much of the work done with patients 
requiring enteral supplementation of their diet has 
involved elemental diets. They have been used 
extensively in inflammatory bowel disease, both as a 
nutritional supplement (83,185) and as a primary 
treatment (13,184,186,187). Successful results have 
been claimed in complicated Crohn's disease (218) 
including the closure of enterocutaneous fistulae (37) 
and the healing of perianal fistulae and fissures (39) 
thus avoiding surgery. The wide range of conditions in 
which chemically-defined diets have been used has 
prompted extensive reviews (138,217) the more recent of 
which concluded that "the diet is of historic interest, 
but there is very little data available substantiating 
or refuting the claims made for it. Assumptions 
concerning its effect on the alimentary tract may be 
wrong. As such its w i d e s p r e a d  use is r e a l l y  
unsupportable, especially in an era where cost 
containment of medical care is a daily issue" (138).
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Perhaps the main criticism of the work done with 
elemental diets is the paucity of controlled studies 
comparing them with either whole food or polymeric diets 
in any clinical situation. In the postoperative period, 
elemental diets conferred no benefits on patients 
compared with polymeric feeds, (67,126) and their use in 
unconscious patients was associated with more 
gastrointestinal side effects and difficulty in 
maintaining nitrogen and other nutritional balances 
(126,128). As a means of reducing faecal weight they 
appear to be no more effective than a well designed low 
residue diet of normal foods (21), although stool 
frequency and consistency may change in healthy 
individuals (134). These results in subjects with 
normal gastrointestinal function are to be expected, as 
pancreaticobiliary enzyme activity was sufficient to 
efficiently digest the whole food diets, and the bowel's 
absorptive capacity was also normal. Despite their easy 
assimilation and absorption, elemental diets should not 
be expected to confer any advantages over polymeric 
diets or normal food under such conditions.
A stronger theoretical case for the use of elemental 
diets can be made in patients with a short length of 
small intestine. The absorptive surface may be markedly 
decreased, and in many cases, particularly where there 
is absence of the distal ileum or colon, the transit
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time through the gut may be extremely short. Despite 
normal pancreaticobiliary secretion it can reasonably be 
postulated that elemental diets might well be beneficial 
to such patients.
The lack of studies of liquid diets in patients after 
extensive bowel resection is even more marked than in 
normal subjects. Kinney et al (137) maintained a young 
patient with an elemental diet after resection of the 
entire jejunum, ileum and ascending colon following 
volvulus of the bowel, thus managing to avoid the use of 
parenteral fluids on a regular basis. In 1969 Thompson 
et al (254) provided a further anecdotal report of a 
patient who retained only 4 inches of jejunum 
anastomosed to mid-transverse colon after a superior 
mesenteric artery thrombosis. Using a chemically- 
defined diet it was possible to provide 25-35% of daily 
calorie needs with a substantial contribution towards 
nitrogen requirements. Trials of medium-chain 
triglycerides and whole food resulted in profuse 
diarrhoea and large negative nutritional balances in 
this patient. Despite treatment with the elemental diet 
regular parenteral therapy was necessary and the patient 
finally succumbed to bacterial endocarditis.
In 1973 Voitk et al (266) reported a series of eight 
patients with extensive small bowel resection in whom an
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elemental diet had been used in the immediate 
postoperative phase of treatment. It is unclear whether 
a trial of food alone in these patients would have been 
equally as successful as the elemental diet. As it was, 
food was tolerated by 4 of the 5 survivors after 19, 21, 
22 and 52 days of elemental diet. It is interesting 
that these patients had a moderate amount of remaining 
intestine distal to the ligament of Treitz, measuring 
130, 180, 200 and 200cm, thus constituting a relatively 
good prognosis group who might have tolerated food 
earlier if challenged.
There are indications that chemically-defined diets may 
not be any better than polymeric diets even in patients 
with the short bowel syndrome. Hecketsweiler et al 
(94), using a perfusion technique studied the absorption 
of nutrients from chemically-defined and polymeric diets 
in the proximal jejunum of 25 healthy volunteers. There 
was no significant difference in the total calorie, 
percentage nitrogen or percentage glucose absorption 
although the absolute values differed because of the 
different make-up of the feeds. In these subjects, the 
proximal 105cm of jejunum was capable of absorbing from 
elemental and polymeric diets respectively, 72% and 83% 
of glucose and 48% and 51% of nitrogen, (86% of fat was 
absorbed from the polymeric diet) presented to the 
intestine by perfusion at the ligament of Treitz. If
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the known capacity for absorption in the duodenum is 
taken into consideration (28,216) it can be postulated 
that patients who retain 100cm jejunum should be able to 
cope with polymeric diets provided that other variables 
such as gastric emptying and bowel transit time remain 
equal.
Since these studies were published, an interesting 
report from Heymsfield et al (98) has suggested that 
chemically-defined diets may indeed be more efficiently 
absorbed than whole food. In one patient with a 250cm 
resection of small bowel and a retained colon, the 
percentage absorption of nitrogen increased from 55% to 
88%, and energy absorption from 72% to 96% when an 
elemental diet was substituted for whole food. A. second 
patient with an unknown length of bowel remaining, but 
with malabsorption responded to a similar regimen. 
Nitrogen and energy absorption increased from 41% and 
72% respectively on whole food to 88% and 96% on an 
elemental diet. In both cases the elemental diet was 
given as a nasogastric tube feed over 20 hours, and 
whole food in six small meals. Balances of nitrogen, 
phophate, calcium and magnesium were positive in both 
patients on the elemental diet.
Nasogastric tubes have been used in some studies 
(98,137,266) to administer elemental diets, usually to
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avoid their unpalatability. Although adequate 
preparation of the patient and the feed, combined with a 
positive attitude from medical and nursing attendants 
has been shown to improve patient compliance (187,242) 
some patients will continue to have problems. They may 
overcome difficulties with taste by drinking food 
supplements quickly, thus presenting a large bolus of 
food to their shortened intestine. It is logical to 
assume that the slower delivery of food via a 
nasogastric tube might be more successful in promoting 
efficient absorption of nutrients by reducing intestinal 
transit rates, increasing mixing of food with digestive 
enzymes and increasing mucosal contact time.
ENTERAL NUTRITION
The techniques of enteral nutrition and the equipment 
available have developed greatly in recent years. The 
large range of convenient, ready-to-use liquid feed 
preparations now available from pharmaceutical and food 
companies has led to increased enthusiasm for the 
treatment from medical and nursing staff. The use of 
fine-bore, silicone rubber feeding tubes has greatly 
improved the acceptability of the procedure to patients 
compared to the days when polyethylene tubes of much 
greater diameter were used, and the development of
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simple peristaltic pumps has completed the hardware 
available for satisfactory nasogastric feeding. Nursing 
protocols have been developed which help to ensure the 
efficient and accurate delivery of a prescribed diet to 
a patient with the minimum of side effects.
The benefits of using liquid diets in the short-term 
support of hospital patients are well documented 
(97,129,282). The complications of enteral feeding are 
less serious and in some cases less frequent than those 
which are often associated with intravenous feeding, in 
addition to which the costs of both feeds and equipment 
are considerably less than the intravenous equivalent.
Although the use of nasogastric feeding tubes was 
described over thirty years ago (68), it is only in the 
past decade that significant progress has been made with 
regard to feeding tubes and liquid diets. In 1976 
Woolfson et al (282) reported the use of a Ryle's tube 
of gauge 8F to maintained the nutritional status of 15 
critically ill patients for up to 41 days using a 
mixture of glucose polymer, egg, and a hydrolysate of 
beef serum proteins. In the United States, central 
venous catheters were used successfully as nasogastric 
tubes to supply an elemental diet to patients (129,191). 
Over the next three years specially developed tubes 
became available, the work of Dobbie (63) and
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Hoffmeister (108) resulting in the Dobhoff tube. This 
is a relatively stiff tube which contains a small 
mercury weight to facilitate passage into the duodenum. 
Another tube, manufactured as the Keofeed tube is made 
of silicone rubber and was used successfully by 
Heymsfield et al (97) when they made a strong case for 
the use of enteral nutrition as an alternative to 
parenteral support whenever this was possible. A wide 
range of silicone nasogastric tubes from many 
manufacturers is now available in an attempt to 
accomodate all personal likes and dislikes amongst 
clinicians and nutritional nursing staff.
When nasogastric feeding is deemed inadvisable because 
of oropharyngeal, oesophageal or gastric pathology or 
surgery, a feeding jejunostomy may be employed to make 
use of the remaining normal intestinal tract. The 
original technique of placing and retaining in position 
fine polyethylene catheters in the jejunum (150,153) was 
refined and adapted using central venous catheters 
inserted via a needle (191). A custom-designed catheter 
has since been designed with prolonged jejunal feeding 
in mind and its use reported by Chrysomilides and 
Kaminski (41).
The reported complications of nasogastric feeding 
include gastric retention with nausea, vomiting and the
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risk of aspiration, abdominal cramps and diarrhoea, and 
a wide range of metabolic disturbances. Many of these 
can be pre-empted by simple precautions. The upper 
gastrointestinal symptoms tend to be worse when liquid 
feeds are given as a bolus, and for this reason a 
constant rate of administration is recommended by most 
authors (63,125,126,129,191,282). To facilitate the 
steady administration of feeds over 24 hours, 
peristaltic pumps are often advocated (63), although 
they may not be entirely necessary in a well-controlled 
hospital environment (125). Abdominal cramps and 
diarrhoea were for a long time considered to be due to 
the hyperosmolar nature of the elemental feeds commonly 
administered. However, it may not be the initial 
osmolality of the feed which is important, but the 
potential osmolality which results from the action of 
pancreatic amylase on glucose polymers in the proximal 
jejunum. Thus a seemingly innoccuous feed may result in 
osmotic diarrhoea in some patients (216). In general, 
there has been disagreement that osmolality is a major 
cause of diarrhoea, and in a number of publications the 
primary cause of diarrhoea whilst receiving nasogastric 
feeding was the concurrent administration of oral 
antibiotics (34,126,282).
The reported metabolic complications of parenteral 
feeding are legion and may occur rapidly because of the
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direct administration of hyperosmolar fluids into the 
vascular system. Use of the enteral route should be 
associated with fewer problems, but, in a prospective 
study of 100 patients fed for a mean of 15.3 days a 
high incidence of metabolic disturbance occurred (265). 
Close reading of this publication reveals that, in most 
cases, the abnormality could be attributed to the 
underlying disease rather than to the nutritional 
support per se. Thus the majority of the cases of 
hyperglycaemia (29% of patients) were associated with 
either diabetes mellitus or systemic infection, and 
hypoglycaemia (2%) and hypokalaemia (8%) occurred in 
those receiving insulin therapy. In a similar way, 
hypernatraemia (10%) was observed in those patients with 
transient diabetes insipidus, and hyperkalaemia (40%) in 
those with renal insufficiency and metabolic acidosis. 
It is likely that the patients' disease and the fact 
that 46% required intensive care were of more 
significance in their metabolic disturbance than their 
tube feeding. Mild liver function abnormalities, with 
elevations of serum aminotransferase and alkaline 
phosphatase levels, were noted in almost 40% of patients 
r e c e i v i n g  n a s o g astric fe e d i n g  (126). T hese 
abnormalities were transient, and no patient developed 
serious hepatic dysfunction.
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HOME ENTERAL NUTRITION
In common with patients requiring other forms of medical 
treatment the majority of those in need of nutritional 
support are treated for a relatively short period in 
hospital following which they remain healthy with no 
longterm therapy. A small number do however fail to 
thrive because of insufficient food intake, often due to 
the exacerbation of food-related symptoms such as 
nausea, vomiting, pain and diarrhoea. Others may have a 
malabsorptive state for which they are unable to 
compensate despite a good appetite. Patients with a 
short intestine often have a combination of both these 
problems.
In many patients borderline malnutrition has been 
satisfactorily treated by regular supplementation of the 
diet with a liquid polymeric feed (90). Patients in 
whom these measures have proved ineffective may be 
taught the techniques necessary to allow safe 
nasogastric or jejunal feeding to continue at home, and 
a small number of reports appear in the literature.
Main et al (161) reported the successful treatment of a 
young man with Crohn's disease who had spent long 
periods in hospital receiving repeated courses of 
parenteral nutrition for malnutrition secondary to his
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Crohn's disease and repeated resections. Despite an 
oral diet of 3000kcal daily he was unable to maintain 
his weight or general health in a satisfactory state. 
The institution of an average daily supplement of 
1700kcal and 55g protein given as a pump-regulated 
nasogastric feed overnight resulted in maintainance of 
weight at 90% of ideal, and haematological and 
biochemical parameters remained within the normal 
ranges. The supplementary feed used was an iso-osmolar, 
lactose-free polymeric preparation (Isocal,Mead Johnston).
Polymeric feeds were also used with success in the 
treatment of 23 patients suffering from a variety of 
conditions and all with protein/calorie malnutrition 
secondary to poor intake (180). A similar technique to 
that of Main et al (161) was employed although the 
delivery time in some cases was as long as 18 hours, 
giving the patient little independence. This appears 
illogical as one of the main aims of home treatment is 
to promote a more independent life-style. In this study 
the authors noted that fewer side effects and better 
weight gain were experienced by those patients whose 
feed delivery was controlled using a pump compared with 
those who were dependent on gravity.
In what was described as "a last resort" Heymsfield et 
al (98) used an elemental diet in two patients with
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Crohn's disease and bowel resections resulting in 
malnutrition. Feeds containing approximately 1300kcal 
were given over 11 to 12 hours by night down a fine-bore 
tube. Feed delivery was again pump-controlled and 
resulted in weight gain and positive nutritional 
balances which were unattainable prior to supplementing 
the diet. The experience of these authors is 
encouraging because it shows that nasogastric nutrition 
at home is feasible and effective in a relatively small 
group of p a t i e n t s  who w o u l d  o t h e r w i s e  s u f f e r  
malnutrition and possible death, or require parenteral 
nutrition with its potential complications.
HOME PARENTERAL FEEDING
The idea of feeding a person intravenously is not new. 
Glucose solutions were used in the early part of the 
twentieth century for both hydration and nutrition, 
casein hydrolysates were used in the 1930*s and fat 
emulsions experimented with, especially in paediatric 
practice. Perhaps the first attempt to sustain a 
patient using all three simultaneously was reported by 
Clark and Brunschwig in 1942 (45). Their patient had 
required radical surgery to resect a neoplasm, resulting 
in the removal of larynx, upper trachea and upper 
oesophagus. For a period of 17 days, nutrients were
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given entirely by the intravenous route. Varying 
quantities of a fat suspension containing olive oil and 
egg lecithin were combined with solutions of glucose, 
saline or a 10% casein digest. The patient remained in 
positive nitrogen balance and maintained his weight 
throughout the test period. During the parenteral 
feeding he remained well and ambulant, with no 
deleterious effects from his treatment other than the 
tendency for the peripheral veins to thrombose after 
infusion of nutrients. He subsequently remained well- 
nourished by infusing nutrient mixtures into a proximal 
oesophagostomy until recurrent tumour caused his death 
one year later.
Although the modern era of parenteral nutrition is often 
dated from 1968 when Dudrick et al (65) reported 
satisfactory growth in dogs fed exclusively with 
intravenous fluids, Wretlind (285) and Schuberth (226) 
had reported the results of their extensive studies on 
the effects of intravenous amino acid solutions and fat 
emulsions in both dogs and man in 1963. Both groups 
reported satisfactory clinical and biochemical results 
after prolonged treatment periods. While Wretlind (285) 
was able to use a soya bean oil emulsion as a calorie 
source, this preparation was not available in the United 
States, and cottonseed oil preparations proved toxic 
(285). Calories were therefore given as concentrated
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glucose solutions, the infusion of which into peripheral 
veins is accompanied by rapid thrombophlebitis. To 
overcome this particular problem, techniques and 
specialised catheters were developed for use in the 
central veins. Broviac et al (35) initially described 
such a catheter made of silicone rubber which was placed 
in the subclavian vein and the tip positioned in the 
right atrium. The other end was then tunnelled 
subcutaneously and emerged on the anterior chest wall. 
This basic idea, with minor modifications (95,213), has 
become the most commonly used method for prolonged 
intravenous access and extensive experience with this 
catheter has now been reported (202). In 1979 Hickman 
et al (99) reported the use of a similar catheter and 
insertion technique in the treatment of leukaemic 
patients requiring bone marrow transplantation. This 
catheter had a wider internal diameter and thicker walls 
to facilitate the repeated administration of blood 
products, antibiotics and other drugs necessary in these 
particular patients.
These two catheter designs, the Broviac and the Hickman, 
have since become the most commonly used catheters for 
longterm parenteral nutrition. However, although the 
Broviac was initially designed to be introduced into the 
subclavian vein through a percutaneous introducer, most 
are now inserted by a direct 'cut down* onto the
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cephalic vein (95,202) causing considerably more trauma 
to the patient (92), but fewer insertion-related 
complications. The percutaneous technique was pursued 
by Powell-Tuck (203) using a finer catheter which 
allowed easier access to the central veins and could be 
tunnelled with the minimum of trauma. A simple clip 
secured the catheter to the skin after insertion. This 
catheter is now available as the Vygon Nutricath. 
Figure 2 shows the three catheters described.
There are many potential complications of intravenous 
feeding. Those related to catheter insertion include 
haematoma formation, pneumo- and haemothorax, and trauma 
to other neck structures such as the subclavian or 
carotid artery, thoracic duct, or brachial plexus. Less 
immediate catheter-related complications such as 
thrombophlebitis, pulmonary embolism, and septicaemia 
may all be life-threatening. The incidence of 
thrombotic complications has been shown to be less when 
silicone catheters are used instead of those made of 
p o l y v i n y l  chloride, p o l y e t h y l e n e ,  and T e f l o n  
(4,114,145,154,158,272). In a prospective radiological 
study, Laidlow et al (146) demonstrated a sleeve of 
fibrinous material encasing all but one of 38 silicone 
catheters placed in the superior vena cava. However, 
none of their patients had radiological or clinical 
evidence of central vein thrombosis or pulmonary
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embolism. It appears that while sleeves on catheters 
are to be expected, thrombosis and pulmonary embolism 
are not necessary accompaniments.
Catheter position appears to be a major determinant of 
thrombotic complications, probably because of inadequate 
dilution of hyperosmolar solutions in smaller veins with 
slower blood flow. Thrombosis is more likely to occur 
when the catheter tip is placed in the subclavian vein 
rather than in the right atrium (145,169) and cortical 
venous thrombosis and cerebral infarction has followed 
the incorrect placement of a catheter in the internal 
jugular vein (245).
Catheter-related sepsis remains potentially one of the 
most dangerous complications of parenteral nutrition and 
may be caused by either bacteria or fungi. The routine 
bacterial culture of the area round the catheter skin 
insertion site has been shown to correlate well with the 
organisms which most commonly cause septicaemia in these 
patients (204,243). To combat these problems and to 
help avoid metabolic upset by improving the efficiency 
of the delivery of the prescribed intravenous fluids 
many centres have formed multidisciplinary teams which 
have been successful in reducing complications and 
simplifying regimens (132,204).
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As in the case of patients requiring supplementary 
enteral feeding, the numbers likely to need prolonged 
parenteral therapy are small. For them, the techniques 
of successful hospital treatment may be adapted for use 
in the home. The phrase "the artificial gut" was first 
coined by Scribner and the group from Seattle, USA in 
1970 (228) who initially used arteriovenous shunts and 
fistulae for prolonged intravenous access at home. It 
was thromboembolic problems with these shunts which 
resulted in the development of the Broviac catheter and 
the subsequent refinements of catheterisation technique.
The first reports of significant numbers of patients 
treated at home appeared in the mid 1970's from centres 
in the United States of America, Canada and Denmark. 
Broviac and his colleagues in Seattle, reported their 
experience with 12 patients in 1974 (36) and extended 
this to 43 patients in 1976 (213), the treatment period 
ranging from 1 to 52 months. In 1973 and 1976, 
Jeejeebhoy and the group from Toronto published a 
comprehensive report giving clinical and biochemical 
details of 12 patients who had been treated at home for 
up to 5 years (121,122). The Toronto experience now 
includes over 70 patients the first of whom is still 
alive and well after 13 years treatment (Jeejeebhoy 
personal communication). In Denmark, home parenteral 
nutrition techniques developed over a similar timescale.
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Ladefoged and Jarnum published their results of 19 
patients surviving at home for 6 to 63 months in 1978 
(143), and further reviewed their extensive experience 
of longterm intravenous nutrition, both in hospital and 
at home, in 1981 (120,145). A combined view of these 
major reports serves well to illustrate the variations 
in technique, and the similarity of application of home 
parenteral feeding at its inception.
In all series the majority of patients treated with home 
intravenous feeding had undergone repeated, or single, 
extensive resections of the small intestine as a result 
of Crohn's disease, or bowel infarction secondary to 
mesenteric vascular disease, both arterial and venous. 
There was therefore a high proportion of patients with 
features of the short bowel syndrome, either with or 
without a residual colon. In addition, a small number 
were treated for active Crohn's disease (36), sometimes 
complicated by enterocutaneous fistulae (36,143). Less 
common diagnoses included systemic sclerosis with total 
intestinal involvement, pseudo-obstruction (122), 
radiation enteritis, acrodermatitis enteropathica, 
systemic mast cell disease and severe postgastrectomy 
dumping and diarrhoea (36). There was no particular age 
group involved, although patients tended to be between 
15 and 65 years of age.
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Silicone catheters were the choice of all groups. The 
Seattle workers naturally favoured the Broviac which was 
also endorsed by the Danes after initial experience with 
non-silicone catheters. ' They noted an increased 
catheter survival time and a decrease in catheter- 
related complications when Broviac catheters were 
substituted. In Toronto, a silicone tube without an 
anchoring Dacron cuff was used, tethered to the skin by 
sutures. This was developed because of their experience 
with skin tunnel infection and the difficulty of 
removing some cuffed catheters. Intravenous solutions 
all contained amino acids and glucose, but Broviac used 
only glucose as an energy source in contradistinction to 
the other groups who included regular lipid emulsion in 
most patients' treatment regimen. Infusate was 
administered from different containers by different 
methods. While Ladefoged and Jarnum (143) were content 
to allow infusion under gravity alone, Broviac et al 
(36) administered fluids from 2 litre glass bottles by 
electric pump with an alarm system to avoid the problems 
of air embolism. The Canadian group approached this 
problem in a different way, employing three, 1 litre 
plastic bags to which was applied a constant pressure 
from pneumatic cuffs. The advantages claimed for this 
system were ease of use, independence from electrical 
power supply and therefore more social freedom for 
holidays and travel, and the increased safety against
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infection and embolism inherent in a totally closed 
system (121).
Catheter sepsis and thrombosis were prominent 
complications in the Danish report (145). However, 
Jeejeebhoy et al (122) reported no catheter sepsis 
arising in patients who had no other site of sepsis, and 
in their 1976 paper (213), the Seattle group reported an 
incidence of only one episode of catheter sepsis per 5.5 
patient years of treatment. When sepsis did occur it 
was potentially serious, both Ladefoged (143) and 
Broviac (36) reporting a single death attributed to 
septicaemia arising from the catheter. Central vein 
thrombosis was most frequent in the Danish series, 
particularly when non-silicone catheters were used. It 
is interesting to note that this occurred despite the 
prophylactic administration of heparin (145).
The success and merit of home parenteral feeding was not 
disputed by any group. Indeed both Broviac (36) and 
Jeejeebhoy (121,122) commented on the remarkable 
improvement in their patients' wellbeing and physical 
capabilities. Most patients in all studies coped well 
with the treatment, although Jeejeebhoy sounded a note 
of warning about the problems likely to be experienced 
by patients with a previous history of depressive 
disease. Two such patients failed to achieve as full
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rehabilitation as the majority in Toronto. The 
psychological problems faced by patients on home 
parenteral nutrition have recently been reviewed and 
include significant depression secondary to the loss of 
the ability to eat (195). A further measure of the 
success of the treatment as a supportive therapy was 
that several patients, 4 in Seattle and 6 in Denmark 
managed to return to an exclusively oral diet after a 
period on parenteral feeding. In general, patients 
resuming oral food did so in less than twelve months, 
although two patients in Denmark restarted an oral diet 
after 13 and 24 months of home parenteral nutrition. 
These successes, and the wellbeing and rehabilitation of 
the majority were felt to more than offset the 
relatively low incidence of complications of a new 
technique.
The growing experience in the United Kingdom since 1978 
has mirrored the early transatlantic experience. A 
register of all the patients who have received 
parenteral nutrition at home has been established (118), 
which reveals that most British patients are aged 
between 20 and 50 years and have a short bowel due to 
resections for Crohn's disease or mesenteric vascular 
disease. The majority are well rehabilitated, being 
able to return to work or look after their family, and 
cope with their treatment without major complications.
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One patient has had successful pregnancies while on 
parenteral feeding (256). Few detailed reports appear 
in the literature as few centres have experience of more 
than a few patients (156,171,275).
The c o n t r i b u t i o n  of the T o r o n t o  g r oup to the 
understanding of nutritional requirements and potential 
metabolic patients in patients receiving longterm 
parenteral nutrition cannot be overemphasised. 
In their initial reports of 1973 (121) and 1976 (122), 
Jeejeebhoy et al found protein requirements to be 
l.lg/kg body weight, coupled with a total calorie 
provision of 27-40kcal/kg with a mean of 32kcal/kg. 
They also demonstrated that the nature of the non­
protein calorie source is important: a patient
receiving glucose alone had a tendency to develop fatty 
hepatic infiltration alone but this could be reversed by 
the regular use of 50-100g intravenous fat daily. 
Withdrawal of the lipid source resulted in the 
recurrence of fatty infiltration in this patient. 
Despite the daily use of fat providing seemingly 
adequate supplies, plasma levels of the essential fatty 
acid, linoleic acid and its metabolites tended to be 
reduced although there was no clinical evidence of 
deficiency.
Vitamin levels in the initial twelve patients from
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Toronto were in general satisfactory with the exception 
of biotin, deficiency of which developed in a 12 month 
old patient receiving long-term parenteral feeding 
(173). Plasma levels of the trace elements copper, zinc 
and chromium were monitored and were found to be normal 
with the exception of chromium, the levels of which 
tended to be low. Frank chromium deficiency was later 
reported to be responsible for glucose intolerance and 
peripheral neuropathy which reversed after chromium 
supplements of 20micrograms daily (123). More detailed 
studies of zinc needs revealed the need for supplements 
of 3-12mg (50-200micromoles) zinc per day depending upon 
the volume of bowel content lost (280).
The longterm survival of patients on exclusively 
parenteral feeding has led to further deficiency 
syndromes being recognised. Abnormalities of some 
erythrocyte and leukocyte enzyme systems have been 
reported associated with low plasma selenium levels. 
Daily intravenous supplements of lOOmicrograms reversed 
both abnormalities (14). Although these findings were 
not clinically detectable, more serious effects of 
selenium deficiency have been reported, including 
generalised myopathy (135) and fatal cardiomyopathy 
(69).
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AIMS OF CURRENT STUDY
This thesis aims to study and discuss certain aspects of 
the management of patients with a short intestine. The 
provision of an oral replacement solution to maintain 
fluid and electrolyte balance and avoid the need for 
intravenous therapy is clearly a desirable goal, for 
although the number of patients with a short small 
intestine is small, a larger number of patients with a 
high output ileostomy could also benefit from the use of 
such a mixture. An 'ideal' solution should effectively 
improve sodium and water balance while being palatable 
and acceptable to patients who will have to take it over 
a prolonged period. It should also be easy to prepare 
from readily available ingredients at low cost. The 
object of the experimental work in this thesis was to 
attempt to identify such a solution using the WHO 
cholera solution as a starting point.
The potential benefits of increasing dietary fat include 
improved palatability which could induce patients to 
increase their total calorie intake with a greater 
chance of compensating for their reduced absorptive 
capacity. The clinical studies using normal food aim to 
determine whether variation in the amounts of dietary 
fat and fibre affects the nutritional value of food for 
these patients, and whether restriction of fat is indeed
\
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a useful way of reducing the amounts of nutrients, 
electrolytes and minerals lost by these patients in the 
stool.
Supplemental enteral nutrition is now an accepted form 
of treatment but the merits of elemental and polymeric 
preparations continue to be debated. A comparison of 
Nutranel with Ensure has been made to show if elemental 
diets are a more efficient way to provide nourishment to 
patients with a reduced absorptive area. In some cases, 
oral and nasogastric administration of the same feed has 
been compared to show if there is merit in the routine 
use of nasogastric tubes rather than simply allowing the 
patient to drink supplements.
Enteral supplements are at present usually given in 
liquid form but it is not known whether their use is in 
fact any more effective than giving normal food. The 
results obtained from the studies of solid and liquid 
foodstuffs have been compared to provide guidelines for 
dietary supplementation.
Techniques of nutritional support, both enteral and 
parenteral have been developed with reliable protocols 
for nursing care and patient instruction. These are 
described together with the medical and social results 
of the treatment given to a number of patients.
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The overall aim of this thesis is to provide some 
logical guidelines for the management of patients with 
different disabilities and requirements and to indicate 
clearly the place of different forms of nutritional 
support in the treatment of the short bowel syndrome.
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METHODS
CLINICAL
Electrolyte Mixtures
All the patients who participated in the tests of 
different carbohydrate-electrolyte mixtures had a 
proximal small bowel stoma, and had needed intravenous 
supplementation to maintain fluid and electrolyte 
balance. Intravenous supplements were continued 
throughout the test period in 6 of the 7 patients. 
Following an overnight fast the patient's jejunostomy 
appliance was emptied and he or she was asked to drink a 
500ml bolus of a test solution over 5 to 10 minutes. 
Jejunostomy effluent was collected over the next three 
hours during which no further oral intake was allowed. 
The complete effluent collections were weighed and 
homogenised using a Silverson Laboratory Mixer 
Emulsifier. Aliquots were kept at -20°C prior to 
an a l y s i s  for sodium, p o t a s s i u m ,  c h l o r i d e  and 
polyethylene glycol.
Liquid Diets
A group of seven patients with proximal small bowel 
stomas participated in tests of two liquid feeds. Before
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beginning the test period, each patient fasted 
overnight. The contents of the jejunostomy appliance 
and urinary bladder were discarded. Each liquid feed 
was freshly prepared in the ward kitchen by the same 
operator (PBM) each day. The patient received a diet 
sheet instructing him or her to take aliquots of feed, 
water or glucose-electrolyte mixture at regular 
intervals throughout the day. All liquids were taken as 
sip feeds by 5 patients and administered by nasogastric 
tube to the other 2 patients because of problems with 
palatability. Each diet was given over a period of 12- 
14 hours, kept constant for each patient. After an 
overnight fast the patients emptied their stoma 
appliance and urinary bladder to complete 24 hour 
collections, and began the next test day. Each patient 
received the diets in random order for 2 or 3 days 
depending on their tolerance, then crossed over to the 
other feed. Each patient's diets were based on their 
body weight and were constructed to contain equal 
amounts of nitrogen, sodium, and total fluid during each 
of the test diets. Total calorie input varied because 
of the difference in nitrogen:calorie ratio of the two 
test feeds. Patients JG,AP,BS and RT required 
intravenous saline and potassium throughout the test 
period to maintain fluid and electrolyte balance.
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Solid Food Diets
Solid food diets were constructed to vary only in the 
quantity of fat and fibre that they contained. Three 
diets were prepared, designated high fat/high fibre, 
reduced fat/high fibre, and reduced fat/normal fibre. 
They were given for 2 or 3 days each in a randomised, 
cross-over manner to 4 patients and stoma and urine 
collections completed as described in the section on 
liquid feeds.
Preparation of Specimens
Stoma effluent specimens were collected into polythene 
buckets with a tight-fitting lid. The complete 24-hour 
specimens were weighed and homogenised. Aliquots were 
taken and kept at -20°C before analysis to ascertain the 
concentrations of sodium, potassium, calcium, magnesium, 
fat and nitrogen. Larger aliquots were freeze-dried to 
determine the dry weight of the effluent and in 
preparation for bomb calorimetry. Twenty-four hour 
urine samples were collected into disposable plastic 
containers. The total volume was measured and an 
aliquot taken and frozen at -20°C. Analysis was later 
undertaken for sodium, potassium, calcium, magnesium and 
urea concentrations. The quantity of nitrogen lost in
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the urine was calculated from the urine urea.
Composition of Solid Food Diets
After discussion with an experienced Dietitian, solid 
food diets were designed to contain similar quantities 
of nitrogen, total calories, electrolytes and minerals, 
w h i l e  varying the a m o u n t s  of fat, fibre and 
carbohydrate. The nutritional .value of each diet was 
calculated from standard food tables (196). Wherever 
possible, individual portions of foodstuffs, for example 
butter, preserves, cheese and soups were used to 
m a i n t a i n  c o n s i s t e n t  intakes. The a m o u n t s  of 
electrolytes and minerals varies with the time of year: 
mean values given in the food tables were used, these 
being sodium 50mg/100g, potassium 150mg, calcium 120mg 
and magnesium 12mg/l00g milk. The water used was 
obtained from the hospital supply and contained 
sodium 1.3mmol/l, potassium 0.2mmol/l, calcium 3.5mmol/l 
and magnesium 0.1mmol/l.
Measurement of Intestinal Length
The length of residual intestine was measured in one of 
two ways. When possible, direct measurement was 
undertaken during surgery by measuring along the 
mesenteric border of the intestine with a steel rule.
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The intestine of patients BS and SG was measured in this 
way. In all other cases, measurements were made on a 
barium small bowel follow-through film by a consultant 
radiologist using an opsimeter.
Statistical Methods
For comparisons between diets and electrolyte mixtures, 
each patient acted as his or her own control. 
Differences were analysed using Student's 't' test for 
paired data.
LABORATORY
Flame Spectrophotometry
The concentrations of sodium, potassium, calcium and 
magnesium in urine and stoma effluent samples were 
m e a s u r e d  u s i n g  a Py e  U n i c a m  S P 9 0 A  f l a m e  
spectrophotometer. The light wavelengths used were; 
sodium 589nm, potassium 766.5nm, calcium 422.7nm and 
magnesium 285.2nm.
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Preparation of Standard Solutions 
Sodium
Using sodium chloride, solutions containing 0.1, 0.2, 
0.3, 0.4, and 0.5 mmol sodium per litre were prepared, 
flamed, and a standard curve constructed.
Potassium
Solutions were prepared using potassium chloride and 
sodium chloride. The sodium was included to standardise 
the depressant effect of light emmitted by sodium on 
that emmitted by potassium. The standard solutions 
contained 0, 0.04, 0.08, 0.12, and 0.16 mmol potassium 
per litre, and 1.2 mmol sodium per litre. When test 
solutions were being processed, standard solutions were 
rechecked after every twenty test samples.
Calcium and Magnesium
Calcium chloride was used to prepare solutions 
containing 0.025, 0.05, 0.075, 0.1, 0.125, and 0.15 mmol 
calcium per litre. Standard solutions for magnesium were 
prepared using magnesium nitrate and contained 0.016, 
0.025, 0.033, 0.041, 0.049 and 0.066 mmol magnesium per 
litre. The light wavelength used for magnesium
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estimations was 285.2nm, and for calcium 422.7nm. 
Measurement of Chloride in Stool
Chloride concentrations in jejunostomy fluid were 
determined using an EEL Chloride Meter (Evans 
Electroselenium Ltd). A solution of sodium chloride 100 
mmol/l was used as a standard. Test blanks consisted of 
buffer, gelatin solution and distilled water.
Measurement of Polyethylene Glycol
The concentration of polyethylene glycol present in 
intestinal effluent was measured using the turbidimetric 
method of Hyden (116) as modified by Malawer and Powell 
(163) and Boulter and McMichael (31) to improve 
stability and reproducibility. The turbidity of samples 
was determined in a spectrophotometer (Unicam SP500 
Series) against a water blank, using a blue photocell 
and a wavelength of 420 nm.
Measurement of Faecal Nitrogen
The nitrogen content of stoma effluent was determined 
using the Micro-Kjeldhal method as described by Wootton 
(283). Three measurements were made of each aliquot of 
intestinal content.
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Measurement, of Faecal Fat.
Faecal fat was measured by the method of van de Kamer 
(264). This method is not entirely suitable for the 
complete extraction of medium chain fatty acids, 
(223) assuming as it does a mean molecular weight of 284 
for fatty acids, equivalent to 16C:0 fatty acids. For 
this reason, gas liquid chromatography was utilised in 
the measurement of fatty acids in those patients who 
tested liquid feeds containing medium chain (8-10 C) 
triglycerides.
Gas Liquid Chromatography
Gas liquid chromatography was used in the determination 
of fatty acids in the jejunostomy effluent of those 
patients who took liquid diets, as 50% of the fat 
contained in Nutranel is in the form of medium chain 
triglycerides. Analysis was performed using a 3.0m x 
2.0mm SP2100 DOH column through which samples were 
injected by an S8 autoinjector. Nitrogen was used as 
the carrier gas at a flow rate of 25ml/minute, and the 
analysis i n t e g r a t e d  using a Pye U n i c a m  4800 
chromatography control centre. To improve resolution of 
isomers, further analysis was performed on a 25m bonded 
phase capillary column (SGE BPE). The identity of 
in d ividual fatty acids wa s  c o n f i r m e d  by mass
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spectrometry on a Dupont 491 instrument. The 
chromatography and mass spectrometry were carried out at 
the Public Health Laboratory Service Centre for Applied 
Microbiology and Research, Porton Down, Salisbury, 
Wiltshire.
Measurement of Urine Urea
Measurement of the urea concentration in urine samples 
was undertaken in the routine chemical pathology 
laboratory at St Bartholomews Hospital, London using a 
Technicon SMA 11, Computer-controlled, Multichannel 
Biochemical Analyser (Technicon Instrument Corporation).
Measurement of Urine Osmolality
Urine osmolality was measured in the same hospital 
chemical pathology laboratory as the urine urea 
concentrations, using an Advanced Digimatic Osmometer 
Model 3D11 (Advanced Instruments Inc).
Bomb Calorimetry
Aliquots of wet faecal homgenate were placed in pre­
weighed conical flasks and the flasks re-weighed. The 
exact weight of the homogenate was determined by
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subtraction of the weight of the empty flask from the 
total. Samples were then frozen at -20°C before being 
connected to a condenser and vacuum pump (Edwards High 
Vacuum pump Model ED 50) and freeze dried. This process 
was continued until a constant weight of flask and 
sample was obtained, usually in 36 to 48 hours. The 
flasks were then reweighed and the weight of dry stool 
determined by subtraction.
The theoretical basis of bomb calorimetry is the 
assumption that complete combustion of a substrate will 
occur in an atmosphere of excess oxygen. The apparatus 
used, a Gallenkamp Ballistic Bomb Calorimeter (Model 
CBB-330-010L) is illustrated in Figures 3 and 4. Samples 
are placed in a crucible inside the combustion chamber 
of the calorimeter. Oxygen is introduced to a pressure 
of 25 atmospheres. A thermocouple is attached to the 
outer casing of the combustion chamber, and the 
galvanometer scale set to zero. The sample is then 
ignited electrically, and the peak galvanometer reading 
noted. The galvanometer deflection is a measure of the 
change in temperature produced by the combustion of the 
sample in the calorimeter. An initial sample was 
combusted to ensure that the galvanometer deflection 
fell in the desired range. The procedure was then 
repeated with a total of six identical samples and the 
galvanometer deflections recorded. A correction factor
FIGURE 3 : Bomb calorimeter combustion chamber with
crucible and cotton fuse in place.
FIGURE 4 Bomb calorimeter with combustion chamber
closed and thermocouple attached ready for 
firing.
for the cotton fuse was subtracted in each case and the 
mean deflection calculated. The calorific value of the 
sample was obtained from the standard curve and a total 
calorific value for the 24 hour effluent collection 
calculated.
A standard curve showing galvanometer deflection plotted 
against kilocalories was produced by combusting multiple 
samples of Analar sucrose. This has a known calorific 
value of 3.96kcal per gram and the thermal emission is 
linear in the region around 4.00kcal. Six samples of 
each of the following weights were used; 0.5, 0.6, 0.7, 
0.8, 0.9, 1.0, and 1.1 grams. The line produced is
shown in Figure 5. Each point represents the mean value 
+ 1SD for a particular weight of sucrose.
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RESULTS
ELECTROLYTE SOLUTIONS
Seven patients took part in tests of five different 
electrolyte replacement solutions. All had previously 
required regular intravenous therapy to maintain 
satisfactory fluid and electrolyte status. Figure 6 
gives the patients' characteristics and an indication of 
their intestinal length measured from the duodeno­
jejunal flexure to their jejunostomy. Six patients had 
required recurrent resections of small and large 
intestine for Crohn's disease. In addition, KB had 
required gastroduodenal surgery leaving a small gastric 
remnant anastomosed to duodenum. Patient JG had 
suffered from radiation enteritis following treatment 
for cervical carcinoma. Full case histories are given 
in the Appendix.
Each subject took each of the test solutions after an 
overnight fast and collected the effluent from their 
jejunostomy for the next three hours. The composition 
of the electrolyte mixtures is shown in Table 1.
The subjects have been arbitrarily divided into two 
groups depending on whether they could subsequently be 
maintained in fluid and electrolyte balance on oral
cm
Gut
Patient TF IW KB SG BS JG AP
Sex 9 9 9 6 9 9 9
Age 26 66 17 37 44 50 45
0 
10
30
50
70
90
110
130
150
Diagnosis
/I /I /I
Crohns Crohns Crohns Crohns Crohns Radiation Crohns
FIGURE 6 : Patients who took part in tests of different
sugar/electrolyte replacement solutions.
Saline Saline Saline Saline Electrolyte
Bicarb. Bicarb. Bicarb. glucose 
Glucose Glucose Maltose Sucrose 'Caloreen'
Concentration
mnol/l
76
9
12
2.5
110
(20g)
17.5
(16g)
294
In 10 other studies small changes were made as shewn in the 
footnote and in Figures 7 and 8.
NaCl 76nmol/l in solution 1 for IW, 85 imol/l for KB.
NaCl 42.5mnol/l and NaHC03 42.5nmol/l in solution 2 for IW and 
KB and one study on TF.
NaCl 115mnol/l and NaHC03 Ommol/l in solution 3 for one study 
on JG.
TABLE 1 : Ccrnposition of electrolyte solutions tested in 46
of 56 studies.
NaCl 90 60 72.5 72.5
NaHC03 30 42.5 42.5
KC1
Ca Gluconate
Glucose 110 110
(20g) (20g)
Maltose 55
(20g)
Sucrose 55
Glucose
Oligosaccharide
(Caloreen)
(20g)
Osmolality
mosm/l 279 284 269 275
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fluids (Group A, subjects TF,JG,IW,SG) or continued to 
require intravenous supplementation (Group B, subjects 
AP,BS,KB). Tables 2 & 3 show the net absorption or 
secretion of sodium, potassium, chloride and water from 
each test solution over the collection period in 56 
studies where 80% or more of the marker polyethylene 
glycol was recovered (81% of the studies). With the 
exception of potassium, these are illustrated in Figures 
7 and 8.
Water, Sodium, Chloride and Bicarbonate
Group A Subjects
a. With or without bicarbonate
Mean absorption of sodium was 24.8mmol (57.5%) from the 
500ml of saline/glucose solution, and 27.8mmol (63.3%) 
from the solution where 30mmol chloride had been 
substituted by bicarbonate (difference not significant). 
Chloride absorption was less from the bicarbonate- 
containing solution but water absorption was similar 
(68.6% versus 63.2%).
b. Glucose versus maltose
Substitution of an equal weight of maltose for glucose 
in the solution, with appropriate increase in sodium 
concentration to preserve isotonicity, resulted in a
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significant increase in sodium absorption to a mean of 
39.2mmol (68.1%) over the saline/glucose solution 
(p<0.02). Chloride absorption was greater with the 
higher chloride concentration in solution 1, but water 
absorption was similar (69.6% and 63.2%).
c. Maltose versus sucrose
Substitution of sucrose for maltose in the two subjects 
tested resulted in less sodium absorption (sucrose 
21.4mmol, maltose 34.0mmol). There was little chloride 
absorption and water absorption was also less (sucrose 
34.6%, maltose 60.0%).
d. Addition of oligosaccharides
Addition of glucose oligosaccharide (Caloreen) resulted 
in absorption of only 15.8mmol of sodium (41.7%) from 
500ml of solution, which was significantly less than 
from the saline glucose solution (p<0.05). Chloride 
absorption exceeded sodium absorption. Mean water 
absorption was 54.6%.
e. Water and tea
Ingestion of 500ml of water or tea resulted in 
absorption of 62.3% of the water and 44.7% of the water 
in the tea, but a marked net loss of sodium and chloride 
in all subjects.
Na mmol
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FIGURE 7 : Sodium, chloride and water absorption and
secretion in patients who were able to stop 
intravenous therapy (Group A ) .
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8 : Sodium, chloride and water absorption a
secretion in patients who continued to 
require intravenous therapy (Group B).
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Group B Subjects
Group B subjects failed to absorb any of the solutions 
sufficiently well to be clinically useful, results 
ranging from a small net secretion to 16.8% absorption 
of sodium, and from 2.4-27.7% of water from the 500ml 
ingested. Water and tea tended to result in a small net 
loss of water, but a large loss of sodium and chloride 
was produced by ingestion of 500ml of both fluids in all 
subjects.
Potassium
In both groups of subjects, there was a small secretion 
of potassium with all the solutions except those 
containing the ion (solution 5, and tea, K=6mmol/l), 
where there was a small net potassium absorption.
Summary
Sodium absorption was greatest from the maltose- 
c o n t a i n i n g  s o l u t i o n  but sucrose and g l u c o s e  
oligosaccharides compared poorly with glucose as 
promoters of water and sodium absorption.
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Ingestion of water and tea led to a negative sodium 
balance in all patients and to a negative water balance 
in the most severely affected.
Group A patients, who were subsequently able to stop 
intravenous fluids and to be maintained in satisfactory 
fluid and electrolyte balance using oral replacement 
could be identified by the fact that they excreted less 
than 250ml from their jejunostomy in the three hours 
after ingestion of a 500ml bolus of the glucose- 
bicarbonate-saline mixture.
Although absolute sodium absorption was greatest after 
the maltose solution, the difference between this and 
the glucose-bicarbonate-saline solution is not 
considered large enough to be clinically important or to 
justify the considerable cost of using maltose routinely 
in oral replacement solutions.
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SOLID FOOD DIETS
Three solid food diets were constructed to contain 
different quantities of fat and fibre while keeping 
other constituents, including nitrogen, total calories 
and fluid input constant. Calcium intake was maintained 
at a similar level in all diets. Although there was a 
range of values for all dietary constituents for the 
group, each patient maintained a relatively constant 
input of each constituent on all diets. A daily 
supplement of 12mmol magnesium in the form of magnesium 
glycerophosphate was given throughout each test period. 
The diet constituents are shown in Table 4.
Four patients completed studies of the three solid food 
diets and provided 2-3 complete 24hr collections of 
stoma effluent and urine on each diet. All had a 
proximal small bowel stoma and retained less than 150cm 
small intestine between the duodeno-jejunal flexure and 
the stoma. Patient details are given in Figure 9. Two 
patients (AP and BS), who usually required supplementary 
parenteral nutrition at home received saline 0.9% with 
additions of potassium chloride to maintain fluid and 
electrolyte balance throughout the test period. The 
results of effluent and urine analysis are given in 
Tables 5 to 8.
Patient
Sex
Age
cm
gut
30 .  
50 -
70 -  
90 -
110  - 
130 -  
150 -
DM BS JG AP
6 9 9 9
49 45 51 44
Diagnosis 
Fasting Output
Crohns Crohns 
430g 81Og
Radiation Crohns 
2015g 1300g
FIGURE 9 : Details of patients taking solid food diets.
Diet 1 (High Fat, High Fibre)
Patient
Nitrogen
9
Fat
g
Fibre
g
Calories
kcal
Calcium
nmol
Magnesium
nmol
Fluid
ml
JG 11.0 68 29 1668 13.8 25.8 4240
DM 13.0 90 28 2022 23.8 28.7 2140
AP 11.7 102 27 2294 20.5 27.0 1960
BS 12.8 106 26 2168 23.6 27.8 1760
Diet 2 (Reduced Fat, High Fibre)
Patient
Nitrogen
g
Fat
g
Fibre
g
Calories
kcal
Calcium
nmol
Magnesium
nmol
Fluid
ml
JG 11.0 44 24 1576 13.8 27.0 4190
DM 12.6 50 29 1694 20.6 28.3 1810
AP 13.0 42 27 1866 23.6 27.6 2160
BS 12.8 43 27 1640 23.6 27.6 1760
Diet 3 (Reduced Fat, Reduced Fibre)
Patient
Nitrogen
g
Fat
g
Fibre
g
Calories
kcal
Calcium
nmol
Magnesium 
nmol *
Fluid
ml
JG 11.2 46 15 1718 17.0 21.0 3820
DM 11.8 46 15 1718 27.5 21.8 2240
AP 12.0 41 14 1847 25.2 21.1 1960
BS 11.5 39 14 1539 22.9 20.8 1635
* Includes daily supplement of 12imol 
TABLE 4 s Constituents of solid food diets.
Diet 1
Weight(g) Calories Nitrogen(g) Fat(g)
Patient Wet Dry Total %absorb. Total %absorb. Total %absorb.
JG 2040 164.3 808 51.6 3.07 72.1 28.8 57.7
EM 1790 150.1 793 60.8 4.50 65.4 33.9 62.3
AP 6507 469.5 2014 12.2 8.26 29.4 67.3 34.0
BS 3742 321.0 1458 32.8 7.44 41.9 41.2 61.2
Diet 2
Weight (g) Calories 
Wet Dry Total %absorb.
Nitrogen(g) 
Total %absorb.
Fat(g) 
Total % absorb
JG 2295 183.9 821 47.9 5.45 50.5 27.1 38.4
DM 1687 121.7 536 68.4 4.55 63.9 14.9 71.2
AP 6183 387.9 1462 21.6 9.89 23.9 24.4 41.9
BS 3672 284.8 1158 29.4 7.76 39.4 28.1 35.6
Diet 3
Weight(g) Calories 
Wet Dry Total %absorb.
Nitrogen(g) 
Total %absorb.
Fat(g) 
Total %absorb
JG 2313 168.8 795 56.9 3.56 68.2 21.6 51.9
DM 1762 128.2 546 68.2 5.81 50.8 11.3 75.4
AP 5786 354.6 1366 26.0 6.62 44.5 26.9 33.8
BS 3574 273.6 1192 30.4 5.74 50.1 23.9 38.7
TABLE 5 : Analysis of the jejunostcny effluent of patients 
taking solid food diets.
Diet 1
Patient
JG
DM
AP
BS
Diet 2 
Patient
JG
DM
AP
BS
Diet 3 
Patient
JG
DM
AP
BS
Sodium Potassium
nmol/kg Total mnol/kg Total
104.8 213.6 10.7 21.8
118.8 212.6 10.3 18.5
92.1 599.3 12.6 82.0
93.3 349.8 14.1 52.7
Calcium Magnesium 
mnol/kg Total nmol/kg Total
6.4 13.1 10.1 21.6
12.7 22.7 10.8 22.4
3.9 25.4 1.5 9.8
5.1 19.1 5.7 21.2
Sodium Potassium
mmol/kg Total mnol/kg Total
89.8 206.2 10.1 23.2
117.5 198.2 10.3 17.3
94.2 582.4 12.2 75.4
91.0 334.0 14.3 52.6
Calcium Magnesium
nmol/kg Total nmol/kg Total
5.3 12.2 7.3 16.7
5.1 8.6 13.1 22.0
3.6 22.2 2.2 13.6
5.2 19.1 5.8 21.1
Sodium Potassium Calcium Magnesium
mnol/kg Total mnol/kg Total mnol/kg Total mnol/kg Total
93.9 238.3 10.0 24.8 5.7 14.2 8.2 20.4
112.4 198.0 11.2 19.7 14.4 25.3 4.3 7.6
106.1 612.0 11.1 64.0 9.0 52.0 2.7 15.6
95.8 344.3 13.0 46.5 5.1 19.2 4.6 16.4
TABLE 6 : Electrolyte and mineral analysis of the jejunostomy 
effluent of patients taking solid food diets.
Diet 1
Patient
JG
DM
AP
BS
Diet 2 
Patient
JG
DM
AP
BS
Diet 3 
Patient
JG
DM
AP
BS
TABLE 7
Sodium Potassium
irmol/l Total mnol/l Total
104.2 146.2 28.2 39.1
4.8 2.3 96.8 45.9
144.0 102.2 100.0 71.0
122.0 130.7 40.7 42.6
Calcium Magnesium 
nmol/l Total mnol/l Total
0.6 0.8 0.3 0.4
0.7 0.3 1.8 0.9
0.4 0.3 0.2 0.14
0.6 0.7 0.8 0.9
Sodium Potassium Calcium Magnesium 
mnol/l Total nrnol/l Total mnol/l Total mnol/l Total
40.0 33.4 39.8 32.0 0.7 0.6 0.4 0.3
4.3 2.0 120.1 49.7 0.8 0.4 1.5 0.6
T # —i • * • ™ 0.2 0.3 0.2 0.3
74.0 94.5 36.0 45.9 0.4 0.5 0.4 0.5
Sodium Potassium Calcium Magnesium 
nrnol/l Total nrnol/l Total mnol/l Total mnol/l Total
170.0 111.3 41.6 27.3 1.8 1.2 0.4 0.3
4.5 2.3 94.4 49.1 1.0 0.5 2.4 1.3
184.0 278.8 65.0 87.8 0.4 0.6 0.2 0.3
128.0 122.9 48.0 46.1 0.5 0.5 1.8 1.7
: Electrolyte and mineral losses in the urine of 
patients taking solid food diets.
Diet 1
Volume Urea Nitrogen Osmolality
Patient ml mnol/l Total g mosm/L
JG 1400 75 105 2.94 236
EM 475 585 281 7.86 905
AP 710 45 32 0.89 357
BS 1120 62 58 1.62 262
Diet 2
Volume Urea Nitrogen Osmolality
Patient ml mnol/l Total g mosm/L
JG 840 95 81 2.26 202
DM 440 503 236 6.61 857
AP 1420 48 68.2 1.91 499
BS 1275 45 57.4 1.61 177
Diet 3
Volume Urea Nitrogen Osmolality
Patient ml rrmol/l Total g mosm/L
JG 655 102 67.1 1.88 350
DM 520 540 280.8 7.86 865
AP 1470 48 71.1 1.99 412
BS 960 90 86.4 2.42 358
TABLE 8 : Analysis of the urine of patients taking 
solid food diets.
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Diets
As shown in Table 4 there was a significant difference 
in the amounts of fat and fibre in each diet. Despite 
encouragement, patients found it difficult to eat larger 
quantities of food while on the low fat diets. This 
resulted in a lower total calorie intake during these 
days. Intakes of fluids, calcium and magnesium were 
similar on all diets.
Stoma Effluent 
Wet and Dry Weight
The mean wet and dry weights of stoma effluent for each 
patient during each diet are shown in Figure 10. Wet 
weight ranged from 1790-6570g on diet 1, 1687-6183g on 
diet 2 and 1762-5786g on diet 3. The dry weights 
folowed a similar pattern, from 150.1-469.5g on diet 1,
121.7-387.9g on diet 2 and 128.2-354.6g on diet 3. 
Only one patient (AP) experienced any appreciable change 
in wet weight between diets. Three patients had lower 
dry weights on the reduced fat diets (Diets 2 & 3), but 
the differences between diets were not significant.
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Calorie Absorption
Wide variation in the absorptive capacity of patients is 
demonstrated, the percentage of available calories 
absorbed ranging from 12.2-60.8% on Diet 1, 21.6-68.4% 
on Diet 2, and 26.0-68.2% on Diet 3, but no one diet 
appeared to provide calories more efficiently than the 
others. A graphic representation of percentage calorie 
absorption from the three diets is shown in Figure 11.
Fat Absorption
Fat excretion from the jejunostomy on different diets is 
demonstrated in Figure 12. There was a tendency to 
higher fat losses while on the high fat diet 1, range 
28.8-67.3g/day compared with 14.9-28.1g/day (diet 2) and 
11.3-26.9g/day (diet 3), which just fails to reach 
statistical significance at the 5% level. The 
percentage of fat absorbed from each diet did not show 
any trend between diets.
801
 , 1  1
FAT High Reduced Reduced
FIBRE High High. Normal
DIET 1 2 3
FIGURE II : Percentage calorie absorption achieved
by patients taking solid food diets.
80 1
9
AP
60 -
40 .
DM
20 -
FAT High Reduced Reduced
FIBRE High High Normal
DIET 1 2 3
FIGURE 12 Daily losses of fat in the jejunostomy 
effluent while taking solid food diets.
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Nitrogen Balance
Losses of nitrogen in effluent and urine are shown in 
Figure 13 and balances of nitrogen input against total 
effluent and urine losses are graphed in Figure 14. 
With one exception (DM) these patients had a reversal of 
the normal pattern of nitrogen excretion, losing more in 
their stool than in the urine. Faecal nitrogen losses 
were high, but patients maintained a positive balance 
on all diets with the exception of DM who experienced 
minor negative balance on diet 3.
Sodium and Potassium
Individual patients experienced variation in the amount 
of sodium lost, but the range of sodium concentration 
remained similar on all diets, 92.1-118.8mmol/kg (diet 
1), 91.0-117.5mmol/kg (diet 2) and 93.9-112.4mmol/kg
(diet 3). Potassium concentration was more constant 
between patients and on different diets, 10.3- 
14.1mmol/kg (diet 1), 10.1-14.3mmol/kg (diet 2) and
10.0-13.0mmol/kg (diet 3). As shown in Figure 15 daily 
losses of sodium and potassium varied considerably from 
patient to patient, but remained similar for each 
individual while taking the different diets.
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Calcium and Magnesium
Calcium loss in the group as a whole was lowest on diet 
2, range 3.6-5.3mmol/kg, compared with 3.9-12.7mmol/kg 
(diet 1) and 5.1-14.4mmol/kg (diet 3). By contrast, 
magnesium concentration tended to be lower on diet 3,
2.7-8.2mmol/kg compared with 1.5-10.8mmol/kg (diet 1) 
and 2 . 2 - 1 3 . 1 m m o 1/kg (diet 2). No s i g n i f i c a n t  
differences in calcium or magnesium excretion occurred 
between diets.
Urine calcium and magnesium losses were universally low. 
Balances of input against combined stool and urine 
losses are shown in Figure 16. Most patients maintained 
a positive balance for both minerals on all diets.
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Summary
Four patients compared the effects of three diets which 
contained significantly different quantities of fat and 
fibre, but maintained other constituents constant. 
Despite their efforts, fewer calories were consumed when 
the diets contained smaller amounts of fat.
Diets with lower fat and fibre content were no more 
benefial than those with higher fat and fibre, stoma 
output, electrolyte and mineral losses being similar for 
each patient on all diets.
Patients maintained a positive nitrogen balance on all 
diets, and absorbed a similar percentage of calories 
from each. When taking a higher fat diet, more fat was 
excreted in the stoma effluent, but the percentage 
absorbed remained relatively constant indicating that 
more fat had been absorbed.
These findings, that low fat diets tend to provide fewer 
calories, that a constant percentage of fat and calories 
is absorbed from diets of different composition, and 
that higher dietary fat had no detrimental effect on 
fluid, electrolyte and mineral losses, suggests that low 
fat diets are not mandatory for all patients with a 
short bowel.
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LIQUID DIETS
Seven patients with a proximal small bowel stoma took 
each of two liquid feeds as their only nourishment and 
provided 1-3 complete 24 hour collections of urine and 
stoma effluent on each feed. The polymeric feed Ensure 
(Abbott Laboratories) was compared with the chemically 
defined feed Nutranel (Roussel). Table 9 gives the 
constituents of each feed and Table 10 the fatty acid 
profile as states by the manufacturers. Table 11 shows 
the amounts given to each patient. The patient group 
consisted of 3 mal'es and 4 females, whose ages ranged 
from 23-51 years. Five patients had had Crohn's disease 
and recurrent intestinal resections, one had had 
radiation enteritis after radiotherapy for carcinoma of 
the cervix, resulting in small intestinal fistulae and 
small bowel resections, and the seventh had suffered 
recurrent enterocutaneous fistulae after a complicated 
colectomy for ulcerative colitis. Figure 17 gives a 
schematic representation of the patients studied. No 
patient retained more than 150cm small bowel, and all 
had an intact oesophagus, stomach, duodenum and 
pancreatico-biliary duct system. The weight of a 24hr 
collection of jejunostomy effluent during fasting varied 
between 430 and 2680g. Two patients, BS and AP were 
unable to tolerate full quantities of either feed. 
Their tests were conducted using half the ideal
Patient
Sex
Age
cm
Gut
0 
20 
40 
60 
80 
100 
120 
140 
160
DM
6
49
XI
SG BS JG
d 9 9
38 45 51
X ^ X " X ^
/ I X I X )
RT
6
44
MS
9
23
AP
9
44
X ^ l
XI
Diagnosis Crohns Crohns Crohns Radiation Crohns
Fasting output g 430 1400 810 2015 2680
Fistulae Crohns 
600 1300
FIGURE 17 : Patients who participated in studies of
liquid diets.
ENSURE NUTRANEL
Protein Source Sodium & calcium caseinate 87% Whey protein
Soy protein isolate 13% isolate
Carbohydrate Hydrolysed com starch 70% Maltodextrin 98.7%
Sucrose 30% Lactose 1.3%
Fat Com oil Com oil 50%
Coconut oil 50%
Nitrogen (g) 0.6 0.64
Fat (g) 3.7 1.0
Carbohydrate (g) 14.6 18.8
Total calories 106 100
Sodium (nmol) 3.7 2.0
Potassium (rrmol) 4.0 3.6
Calcium (nmol) 1.4 1.2
Magnesium (nmol) 0.89 0.42
Chloride (nmol) 4.1 2.5
Phosphorus (nmol) 1.8 1.2
Copper (micrcmol) 2.0 2.0
Manganese (micromol) 4.0 7.0
Iron (micrcmol) 17.0 18.0
Zinc (micromol) 25.0 11.0
Iodine (micranol) 0.064 0.047
TABLE 9 : Consituents of liquid diets per 100ml.
ENSURE NUTRANEL
Chain length Name %
6:0 Caproic
8:0 Caprilic
10:0 Decanoic
12:0 Laurie 0.13
14:0 Myristic 0.2
16:0 Palmitic 11.7
16:1 Palmitoleic ^ *
18:0 Stearic 2.3
18:1 Oleic 25.2
18:2 Linoleic 59.23
18:3 Linolenic 0.93
20:0 Arachidic 0.3
Others
%
0.5
30.5
18.5 
0.5 
“* • 
5.3 
0.2 
1.2
16.3
26.0
0.5
^
0.5
TABLE 10 : Fatty acid profiles of liquid feeds : percent of fat.
DAILY INPUT : ENSURE
Patient kcal Nitrogen
g
Fat
g
Na
nmol
K
nmol
Ca
nmol
Mg
nmol
Fluid
ml
JG 1875 10.5 64.8 64.8 70.0 24.5 15.6 2500
SG*** 1867 10.4 63.9 63.9 69.0 24.2 15.4 2900
MS 2050 11.6 71.4 71.4 77.2 27.0 17.2 3000
DM 2000 11.3 69.6 69.6 75.2 26.3 16.7 3000
AP* 1000 5.7 34.8 34.8 37.6 13.2 8.4 1500
BS* 1000 5.7 34.8 34.8 37.6 13.2 8.4 1500
RT 2000 11.3 69.6 69.6 75.2 26.3 40.7** 2500
DAILY INPUT : NUTRANEL
Patient kcal Nitrogen
g
Fat
g
MCT
g
Na
nmol
K
nmol
Ca
nmol
Mg
nmol
Fluid
ml
JG 1680 10.5 16.8 8.2 33.5 59.2 19.3 6.7 2500
SG 1950 11.5 18.4 9.0 36.8 64.9 21.2 7.4 3050
MS 1856 11.6 18.6 9.1 37.1 65.4 21.3 7.4 2900
DM 1804 11.3 18.0 8.8 36.1 63.6 20.8 7.2 3000
AP* 904 5.7 9.0 4.4 18.1 31.9 9.3 3.6 1500
BS* 904 5.7 9.0 4.4 18.1 31.9 9.3 3.6 1500
RT 1804 11.3 18.0 8.8 36.1 63.6 20.8 31.2** 2500
* Able to tolerate half quantities only.
** Includes daily supplement 24 nmol magnesium glycerophosphate. 
*** Incomplete diet on one test day.
TABLE 11 : Constituents of liquid diets given to each patient.
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quantities. In presenting the results the mean values 
for each parameter on each diet is used for comparisons 
and are shown in Tables 12 and 13.
Wet and Dry Weight
The mean wet and dry weights of stoma effluent for each 
patient on each diet are shown in Figure 18. There is 
wide patient-to-patient variation in wet weight on both 
diets, from 1316-2917g on Ensure, and from 1557-3802g on 
Nutranel. A similar pattern is present for dry weight, 
being in the range 82.5-191.8g on Ensure, and 66.0- 
254.5g on Nutranel.
Calorie Absorption
The percentage of available calories absorbed from each 
feed is shown in Figure 19. There is again a wide 
variation from patient to patient, absorption ranging 
from 35.6-79.9% on Ensure, and from 28.7-78.9% on 
Nutranel. With the exception of patient RT there was 
little difference between feeds for each patient.
WET WEIGHT DRY WEIGHT
9
250
200
SG
150 BS
RT
JG
MS
AP
100
DM<
4000
3000
JG
R T
SG
BS
2000
AP
DM
MS
1000
Ensure Nutranel Ensure Nutranel
FIGURE 18 : Wet and dry weights of jejunostoray effluent
from patients taking liquid diets.
CALORIE ABSORPTION
100
80
Absorption
60
40
20
DM »  
RT *
MS
AP
SG *  
BS •
■ I.—
Ensure
1
Nutranel
FIGURE 19 s Percentage of calories absorbed by patients 
while taking liquid diets.
Weight(g) Calories Nitrogen(g) Fat(g) *
Patient Wet Dry Total %absorb. Total %absorb. Total %absorb.
JG 2917 131.5 616 66.9 2.82 73.1 27.8 57.1
SG 2010 191.8 1149 39.5 4.23 59.3 *’ • ^
MS 1316 124.0 695 66.2 2.57 77.8 29.8 58.3
DM 1783 82.5 402 79.9 2.99 73.5 18.8 73.0
AP 1905 121.3 593 41.7 1.71 70.0 23.9 31.3
BS 2414 149.8 644 35.6 3.61 36.7 14.0 59.8
RT 2562 139.5 476 76.2 2.15 81.0 20.2 71.0
Sodium Potassium Calcium Magnesium
nmol/kg Total nmol/kg Total mnol/kg Total nmol/kg Total
JG 97.0 283.4 11.9 34.4 3.5 10.2 9.3 24.7
SG 74.5 148.1 11.5 23.3 5.7 11.6 8.9 16.9
MS 92.0 121.1 11.5 15.2 18.8 24.7 17.5 23.1
DM 108.0 192.6 8.7 15.4 7.0 12.8 7.2 12.8
AP 100.1 190.1 9.7 18.5 21.2 40.9 4.2 8.0
BS 96.4 232.9 11.7 27.8 3.8 9.1 3.0 7.2
RT 66.2 169.6 8.8 22.5 6.5 16.7 5.5 14.1
= samples lost during analysis.
* Measured by the method of van de Kamer
TABLE 12 : Analysis of the jejunostcrny effluent of patients taking 
Ensure.
Weight(g) Calories Nitrogen(g) Fat(g) *
Patient Wet Dry Total % absorb. Total % absorb. Total % absorb.
JG 1924 104.7 416 75.0 2.44 77.5 15.1 10.1
SG 1794 243.0 1376 28.7 3.31 71.2
MS 1557 128.0 508 72.4 2.65 77.2 7.48 60.2
DM 1641 66.0 377 78.9 2.77 75.5 4.0 77.8
AP 2366 163.7 596 33.4 2.96 48.1 5.4 40.0
BS 2303 158.6 587 34.5 3.49 38.8 4.9 45.6
RT 3802 254.5 1019 43.0 4.51 61.9 16.6 7.8
Sodium Potassium Calcium Magnesium
nmol/kg Total nmol/kg Total nmol/kg Total mmol/kg Total
JG 97.2 186.4 10.5 20.1 6.7 13.0 1.3 2.5
SG 70.1 125.4 12.2 21.8 16.7 29.3 7.5 13.1
MS 81.5 126.9 13.8 21.3 13.0 19.6 5.5 7.4
DM 98.9 162.3 10.4 17.1 6.3 10.3 4.1 6.7
AP 86.4 201.1 11.2 26.1 7.0 16.9 2.2 5.1
BS 88.9 205.9 10.5 24.8 4.9 11.2 1.6 3.6
RT 67.0 254.2 10.7 39.9 3.5 13.1 3.4 14.3
Sairples lost during analysis 
* Measured by the method of van de Kamer.
TABLE 13 : Analysis of the jejunostomy effluent of patients taking 
Nutranel.
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Fat Absorption
Results for six patients are shown in Figure 20. 
Samples from patient SG were lost prior to fat analysis. 
Measured by the method of van de Kamer (264), the 
percentage of available fat absorbed was 31.3-73.0% on 
Ensure, and 7.8-77.8% on Nutranel. Daily fat losses 
were significantly less (p<0 .0 1 ) for all patients when 
taking Nutranel, a result which is not surprising as the 
intake of fat from Nutranel was approximately 25% of 
that from Ensure. Although RT and JG experienced a 
striking reduction in percentage fat absorption when 
taking Nutranel, differences for the other patients were 
less marked, and no significant trend was seen in the 
group as a whole.
Gas liquid chromatography of effluent samples allowed 
identification and measurement of individual fatty acids 
excreted by each patient on each feed. Medium chain 
triglycerides (8 - 1 0 carbon atoms) were excreted in very 
small quantities by all patients. There was higher 
excretion when patients took Nutranel, which contained 
half its fat as MCT, than when they took Ensure, which 
contained no MCT. The percentage fat absorption was 
little different on Ensure than on Nutranel. Tables 14 
and 15 give the results of chromatographic analysis of 
effluent samples obtained for each feed.
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When gas liquid chromatography was used to measure 
individual fatty acids, the values obtained for total 
fat losses were lower for all patients on both feeds, as 
shown in Table 16. The reasons for this discrepancy are 
not clear, but there were several differences in the 
methods used. The van de Kamer method is a titrimetric 
method, and as such may measure acids other than fatty 
acids whereas the chromatography was specific for fatty 
acids. Wet stool was used for the van de Kamer in 
contrast to the chromatography when the stool was dried 
prior to analysis. It is possible that some volatile 
fatty acids were lost during this preparation.
Nitrogen Balance
Figure 21 demonstrates the nitrogen balance for each 
patient on each feed. The balances are derived from the 
values of calculated nitrogen input, and the measured 
losses as faecal nitrogen and urine urea converted to 
nitrogen. A positive balance was maintained on both 
feeds by all patients. With the exception of DM there 
was a strong tendency for the group to lose more 
nitrogen from their stoma than in the urine.
12
10
8
6
4
2
JG 
E N
%
A
m
SG 
E N
MS 
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i
DM AP 
E N E N
%  
—
BS RT 
E N E N
77
1
% 7.
7 *7 "
Urine nitrogen
Stool nitrogen
Positive nitrogen balance
E Ensure 
N Nutranel
FIGURE 21 : Nitrogen balances of patients
while taking liquid diets.
Ensure Nutranel
Patient van de Kamer 
g/24hr
GLC
g/24hr
van de Kamer 
g/24hr
GLC
g/24hr
JG 27.8 11.1 15.1 5.5
MS 29.8 22.3 7.4 7.0
DM 18.8 7.9 4.0 1.1
AP 23.9 10.1 5.4 5.6
BS 14.0 9.2 4.9 1.6
RT 20.2 10.8 16.6 17.1
Ensure Nutranel
Patient van de Kamer 
% absorbed %
GLC
absorbed
van de Kamer 
% absorbed %
GLC
absorbed
JG 57.1 82.9 10.1 62.3
MS 58.3 68.8 60.2 62.4
DM 73.0 88.6 77.8 93.9
AP 31.3 71.0 40.0 37.8
BS 59.8 73.6 45.6 82.2
RT 71.0 84.5 7.8 5.0
TABLE 16 : Fat loss in jejunostomy effluent measured by the 
van de Kamer method and gas liquid chromatography.
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Sodium and Potassium
Figure 22 shows the mean concentration of sodium and 
potassium present in the stoma effluent of each patient 
whilst taking each liquid diet. There was a wide range 
of sodium concentration while taking each feed, 6 6 .2 - 
108.0mmol/kg on Ensure and 67.0-98.9mmol/kg on Nutranel, 
and a tendency for patients to lose less sodium while 
taking Nutranel than while taking Ensure which was not 
statistically significant. The concentration of 
potassium in stoma effluent was much less variable in 
each group, 8.7-11.8 mmol/kg on Ensure and 10.4- 
13.8mmol/kg on Nutranel, with minimal variation for 
individual patients. There was no statistically 
significant difference in sodium or potassium 
concentration in stoma effluent between the two feeds. 
Mean daily balances of oral intake versus stool losses 
for sodium and potassium are shown in Figures 23 and 24. 
Each patient lost more than lOOmmol sodium daily on each 
feed, and the balances were strongly negative in four 
patients, and precarious in the remaining three, 
demonstrating the need for supplementation in these 
patients by either the intravenous or oral route. 
Intravenous saline with potassium supplements was given 
to JG, AP, BS and RT throughout the test periods. There 
was no consistent difference between diets. Patients AP 
and BS had notably high losses even on half quantities
SODIUM LOSS POTASSIUM LOSS
40110
DM
- AP 
JG
100
MS
Na
mmol/kg
mmol/kg
SG
RT
NutranelEnsure
 r
o *-
X
Ensure Nutranel
FIGURE 22 : Sodium and potassium concentration
in the jejunostomy effluent of patients 
taking liquid diets.
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of feed. Daily potassium losses were similar on both 
feeds in all but two cases, and all patients remained 
well without recourse to intravenous supplements.
Calcium and Magnesium
Calcium concentration ranged from 3.5-21.2mmol/kg on 
Ensure, and from 3.5-16.7mmol/kg on Nutranel. Although 
three patients experienced marked differences in calcium 
concentration on the two feeds, the other four lost 
calcium in similar concentrations on both feeds. Figure 
25 shows the mean daily calcium balances of oral input 
versus stool losses for each patient. Only AP and SG 
experienced any difference in total calcium excretion 
between feeds.
The range of magnesium concentration in stoma effluent 
was higher on Ensure, 3.0-17.5mmol/kg, than on Nutranel, 
1.3-7.5mmol/kg. The effluent of all patients had a 
lower magnesium concentration when they were taking 
Nutranel, the difference being significant at the 5% 
level. Figure 26 shows the mean daily balance of stool 
losses versus oral intake of magnesium for each patient. 
Six patients lost less magnesium while taking Nutranel 
than while taking Ensure. This difference was 
significant at the 5% level.
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Summary
A comparison of an elemental feed and a polymeric feed 
was completed by seven patients with a short intestine. 
Although their stoma losses were considerable, the 
quantities lost by each patient were remarkably 
consistent from day to day. All patients had a strong 
tendency to sodium depletion as demonstrated by the 
sodium balance data.
Even in the most severely affected patients, the 
elemental diet failed to confer any benefit, either by 
promoting better nitrogen balance and calorie 
absorption, or by reducing intestinal losses, when 
compared with the polymeric feed.
Although patients lost less magnesium in their stoma 
effluent when taking the elemental diet, this is likely 
to be due to the lower intake on that diet, and balances 
were little different on the two feeds.
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NASOGASTRIC VERSUS ORAL FEEDING
To ascertain whether there was any benefit to be gained 
from giving a liquid feed by nasogastric tube at a 
constant slow rate, rather than as an oral supplement 
taken as frequent small drinks, three patients took 
equal quantities of the same feed by each method over 
12-14 hours per day, for 2-3 days. Patients MS and RT 
received Ensure, WD took Nutranel. The study protocol 
was identical to that used for the tests of liquid 
diets. The periods of nasogastric or sip feeding were 
conducted in random order. Throughout both test periods 
RT took an oral supplement of 24mmol magnesium as the 
glycerophosphate. The constituents of the feeds given 
to each patient are shown in Table 17 and patient 
details in Figure 27. Table 18 summarises the effluent 
analyses.
Wet and Dry Weight
There was a tendency for all patients to lose less stoma 
effluent on the nasogastric feeds than when taking sip 
feeds as shown in Figure 28. Wet weights for 
nasogastric feeds ranged from 749-2562g compared with 
895-3556g on sip feeds. The corresponding ranges for 
dry weights were 58-139.5g and 73-240.4g respectively.
Patient
Sex
Age
cm
Gut
20
40
60
80
100
120
WD
6
49
140
Diagnosis Crohns
RT
6
44
MS
?
23
Crohns Crohns
FIGURE 27 : Patients who took liquid diets by both
oral and nasogastric routes.
WET WEIGHT DRY WEIGHT
3500 JRT
3000
9
2500
2000
1500 - MS
1000 WD'
500
NasogastricOral
350
300
250 RT
200
150 MS
100
WD
50
NasogastricOral
FIGURE 28 : Wet and dry weights of jejunostomy effluent
of patients taking oral and nasogastric diets.
Patient Calories Nitrogen Fat Na K Ca Mg Fluid
g g nmol nmol nmol nmol ml
MS 2050 11.6 71.4 71.4 77.2 27.0 17.2 3000
RT 2000 11.3 69.6 69.6 75.2 26.3 40.7* 2500
WD 2090 13.2 21.1 42.2 74.4 24.3 8.5 2850
Fluid indicates total intake and includes feed, water and 
electrolyte mixture used to maintain sodium and water input 
constant.
* Taking 24nmol magnesium glycerophosphate supplement daily.
TABLE 17 : Constituents of liquid feeds used in the comparison
of oral and nasogastric feeding.
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Nitrogen Absorption
The percentage of ingested nitrogen absorbed by each 
patient from each feed is shown in Fig 29. Two patients 
absorbed more from the nasogastric feed than from the 
oral diet. The percentage of nitrogen absorbed was 
similar to that of fat, 62.0-70.8% from the oral feed, 
and 66.2-81.0% when given by nasogastric tube.
Calorie Absorption
Figure 30 demonstrates that there was little difference 
in the percentage calorie absorption between the two 
methods of feed administration. On sip feeds the 
subjects absorbed from 47.9-84.5% and on nasogastric 
feeds from 6 6 .1 -8 6 .8 % of available calories.
Fat Excretion and Absorption
There was no discernable pattern in the losses of fat. 
The subject taking the low fat preparation Nutranel 
(WD), consistently lost less fat than those taking 
Ensure, but the percentage of fat absorbed was similar. 
The absorption was not affected by the method of feed 
administration, being 66.5-84.6% from sip feeds and
100
80
WD
MS
RTi
60
40
20
NasogastricOral
FIGURE 29 : Percentage of nitrogen absorbed from liquid
diets given orally or by nasogastric tube.
100
WD
80
60
RT
40
20
Oral Nasogastric
FIGURE 30 s Percentage of calories absorbed from liquid 
diets given orally or by nasogastric tube.
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69.7-83.2% from nasogastric feeds. Daily fat losses 
measured by gas liquid chromatography are shown 
graphically in Figure 31.
Sodium and Potassium
The concentrations of sodium and potassium in the stoma 
efluent varied little. As a consequence, the total daily 
losses shown in Figure 32 depended upon the total 
volume of effluent losses and varied accordingly.
Calcium and Magnesium
Figure 33 demonstrates that there were no significant 
differences in calcium and magnesium losses between sip 
and nasogastric feeds. Patients MS and RT, with a higher 
intake of magnesium, tended to lose more than WD.
FAECAL FAT FAT ABSORPTION
100
WD
MS
RT
NasogastricOral
25
RT
20
MS
15
10
5
WD
Oral Nasogastric
FIGURE 31 Daily losses of fat in jejunostomy effluent 
expressed as grams/24hr and as a percentage 
absorbed.
SODIUM POTASSIUM
60
350
RT
RT
300
mmolmmol
250 40
200
WD
150 MS
MS
100
NasogastricOralNasogastricOral
FIGURE 32 : Daily losses of sodium and potassium in the
jejunostomy effluent while taking oral and 
nasogastric diets.
CALCIUM MAGNESIUM
40
30
20
mmol
10
FIGURE 33
WD'
30
MS,
RT'
20
mmol
RT
10
NasogastricOralNasogastricOral
Daily losses of calcium and magnesium 
in the jejunostomy effluent while taking 
oral and nasogastric diets.
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Summary
A small study of oral and nasogastric administration of 
liquid diets was completed. Although the numbers were 
too small for statistical analysis, there are some 
interesting trends in the results.
When taking feeds by nasogastric tube, there was a 
tendency for effluent volume and electrolyte losses to 
be lower.
Higher percentages of available calories and nitrogen 
were absorbed from the nasogastric feeds and two of the 
three patients absorbed more fat than from the oral 
diet.
These preliminary results suggest that nasogastric 
administration of liquid feeds may be more effective 
than oral administration. The benefits may be increased 
as the rate of administration is decreased.
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HOME ENTERAL NUTRITION
A method of self-intubation was devised, and patients 
were taught to pass a soft fine-bore silicone-rubber 
tube on themselves. The tube used (Vygon 2395.06) has 
no stilette, thus avoiding the risk of traumatising the 
oropharynx and oesophagus, and is passed slowly with 
frequent sips of water as it is pliable and cannot be 
advanced only by pushing. The use of a fine silicone 
tube removes much of the discomfort usually associated 
with nasogastric intubation and encouraged good patient 
compliance as confirmed by their clinical progress.
All patients learned the technique quickly and were able 
to pass the tube after a few minutes practice. When the 
tube has been advanced to a mark 60cm from its tip, 
juice is aspirated using a small (2 ml) syringe and 
gentle suction, and tested for acid with litmus paper. 
The position is regarded as satisfactory only when acid 
has been obtained, and the tube is retained in place by 
taping it to the patient's cheek and nose. The feed is 
placed in a reusable enteral feeding bag with integral 
giving set (Viomedex VX516) and the rate of infusion 
controlled using a simple peristaltic pump (Viomedex 
enteral nutrition pump). Figures 34 and 35 show the 
pump and feeding bag used, and Figure 36 shows a patient 
passing her tube and setting up her infusion.
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Six patients have used this system with considerable 
success. Five have administered a liquid feed , and one 
(JG) has used the technique to give 2 litres of 
glucose/electrolyte mixture overnight to maintain water 
and sodium balance. Of the five patients who required 
nutritional supplements three, DM, MS and WD had a short 
small intestine and weight loss despite a good appetite 
and dietary intake. The other two, CW and MW, had 
active inflammatory bowel disease with anorexia, 
abdominal pain and diarrhoea resulting in an inadequate 
intake. Details of these five patients are given in 
Table 19 and. case histories of all patients appear in 
the Appendix.
Patients gained weight at a mean rate of 0.54kg/week 
(range 0.42-0.61kg/week) over the first 12 to 16 weeks 
of treatment, following which it was possible for some 
patients to decrease the frequency and quantity of their 
nocturnal supplements. One patient (CW) who had 
profound hypoalbuminaemia of 15g/l at the start of 
treatment regained normal levels of 35g/l during 
therapy. No patient suffered regurgitation or 
aspiration of the feed, and there were no metabolic 
complications. The two patients with stomas noticed an 
increase in the amount of effluent produced overnight, 
but did not have to empty their appliance more 
frequently than usual. Patients CW and MW underwent
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further surgery, proctocolectomy and proctectomy with 
ileostomy respectively, following which their symptoms 
abated, allowing satisfactory nutrition without 
nocturnal supplements. Patient DM has been able to 
discontinue nasogastric feeds since attaining his ideal 
weight but continues to require liquid supplements by 
day to maintain his weight. The other two patients, MS 
and WD, continue to administer nocturnal feeds 
intermittently to maintain their body weight. MS also 
administers glucose/electrolyte mixture overnight when 
needed. Figure 37 demonstrates the weight gained by 
these patients while taking nocturnal nasogastric 
supplements.
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FIGURE 37 Changes in body weight before and during 
supplemental nocturnal nasogastric feeding.
Patient DM MS WD CW
Age 48 22
Sex M F
Diagnosis Crohn's Fistulae
Remaining 
small gut (cm) 150 80
Remaining
colon None None
Stana Yes Yes
Wt Loss 
(% IBW) 15.6 32.8
Feed Used Isocal Ensure
Calories 1500 1000
Nights/week 5 7
Wt gain 
(kg/week)* 0.50 0.46
Wt gain 
(Total kg) 14.4 6.5
Weight before 
treatment (kg) 65.0 39.0
Weight after 
treatment (kg) 79.4 45.5
Ideal weight 
(kg) 77.0 58.0
* Weight gain over first 12-16
TABLE 19 : Details of patie]
nasogastric feed
49 15 49
M M F
Crohn's Crohn's Ulcerative
colitis
130 All All
Left All Caeco-rectum
No No No
22.3 46.3 31.5
Nutranel Isocal Isocal
2000 1500 1125-750
1 1 1
0.58 0.61 0.42
9.3 9.7 5.5
51.3 26.3 39.4
60.6 36.0 44.9
66.0 49.0 57.5
receiving nocturnal
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HOME PARENTERAL NUTRITION 
Catheter Insertion and Care
The technique used for the insertion of central venous 
catheters for home parenteral feeding is essentially the 
same as the that developed by Powell-Tuck for. use in 
inpatients (203). The method is illustrated in Figure
38. The s u b c l a v i a n  vein is e ntered by the 
infraclavicular route through a small skin incision. 
The catheter is fed into the vein through the introducer 
and its position in the superior vena cava checked 
radiologically before proceeding further. Chest X-ray 
films showing the correct positioning of catheters 
inserted from right and left side are shown in Figure
39. The skin tunnel is made by passing a second, longer 
introducer subcutaneously from a point medial to the 
nipple to the primary insertion site . The catheter is 
then passed down this introducer, a small portion of 
which is retained at the skin entry site. This ensures 
secure fixing of the catheter in the clip which is then 
sutured to the skin and covered with an occlusive 
dressing. The procedure is carried out in a specially 
designed unit with laminar air flow under totally 
aseptic conditions. Recently, cuffed catheters have 
been inserted using a modification of this technique.
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Patients are trained to care for their catheter, and 
learn the aseptic procedures necessary for setting up 
and changing infusions, heparinising the catheter, and 
changing the dressing. They must also learn and 
understand the alarm systems of the infusion pump, and 
receive some education about relevant basic anatomy and 
physiology. The training is undertaken by a Nursing 
Sister with a special interest in nutritional care with 
the aid of a patient manual which explains the treatment 
and its rationale. Each procedure and the equipment 
necessary is described in a detailed step by step 
manner. Figure 40 shows representative pages from the 
manual.
Fluid Administration
Solutions of amino acids, glucose, electrolytes, 
minerals and trace elements are administered from a 
single 3-litre bag (Travenol Laboratories Ltd.). When 
stored in a domestic refrigerator they have a shelf life 
of four weeks. Additions of vitamins are made by the 
patient immediately prior to infusion, because of their 
tendency to degradation with time and when exposed to 
light. To allow maximum patient freedom by day, the 3- 
litre bag is usually given during the night over 10-14 
hours. If additional electrolyte solutions are needed,
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these are given separately from 1 or 2 -litre containers. 
When intravenous fat is needed it is usually given 
before the 3-litre bag.
All home parenteral feeding patients control the rate of 
their infusion overnight using a sophisticated 
volumetric pump with multiple alarm systems. The pump 
chosen was the Valleylab IV5000 and latterly the IV6000B 
(Kontron Instruments Ltd). The main benefit of these 
pumps is that when setting up an infusion, the giving 
set can be primed by gravity flow without touching the 
pump. This greatly simplifies this aseptic procedure 
for the patient. The fact that the infusion can be run 
by gravity allows patients to move round their home 
without the encumbrance of the pump, for example when 
cooking or visiting the toilet. A number of coathooks 
strategically placed round the house from which to hang 
the infusion bag allows maximum mobility.
Patients Treated
From January 1980 to July 1984, sixteen patients 
received intravenous fluids at home. One patient (PS) 
had two courses of home parenteral nutrition having 
failed to consistently thrive because of recurrent 
Crohn's disease. Eight patients had Crohn's disease,
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seven with a short intestine after recurrent resections, 
and three with extensive active disease in their 
remaining gut. Four others had a short bowel, following 
intestinal resection for mesenteric vein thrombosis in 
two, after resection of mesenteric desmoid tumours in a 
third, and after radiation enteritis and resections in 
the fourth. Chronic bowel obstruction prevented oral 
nutrition in three patients, one with a large desmoid 
tumour, one with systemic sclerosis, and one with a 
hollow visceral myopathy and "pseudo-obstruction". One 
patient had severe malabsorption and brittle diabetes 
after pancreatectomy for chronic pancreatitis, and one 
had radiation enteritits. Patient details are given in 
Table 20.
Fluid Regimens
With one exception (PS), patients administered fluids 
every night, and all but three (KB,TF,AP) received three 
litres each infusion. AP required five litres daily to 
replace large jejunostomy losses while TF and KB were 
able to remain well on two litres daily. Three 
patients, KB, GF and RT used electrolyte solutions only 
to maintain fluid and electrolyte balance. Seven 
patients, CD, ED, KD, SG, AL, JS and PS were prescribed 
fat emulsion (Intralipid 1 0 %) two or three times weekly.
Patient Age Sex Diagnosis
SG 33 F Crohn's
CD 43 F Crohn's
PS 29 F Crohn's
PS 31 F Crohn's
KB 18 F Crohn's
TF 29 F Crohn's
FT 45 M Crohn's
BS 47 F Crohn's
AP 46 F Crohn's
ED 51 F Mesenteric 
Infarct, UC, 
Ca colon
PW 40 F Mesenteric
Infarct
JS 44 F Desmoid
Resection
GF 44 F Radiation
Enteritis
AL 44 M Systemic
Sclerosis
AS 19 F Desmoid
KD 21 F Visceral
Myopathy
DP 25 F Pancreatitis
Diabetes
Indication 
for HPN
Active disease
Active disease 
Short hovel
Active disease 
Short hovel
Active disease 
Short bcwel
Short bowel
Short hovel
Short hovel
Short bovel
Short bovel
Short bovel
Short bovel
Short bovel
Short bovel
Obstruction
Obstruction
Obstruction
Malabsorption
Sterna
No
Yes
No
No
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
No
No
Yes
No
TABLE 20 : Details of patients Who received heme 
parenteral nutrition.
Patient Fluids Lipid Duration Catheter Complication Rehab.
l/day ? (months) (no:) Grade
SG 3 Yes 5 1 1
CD 3 Yes 3 * 2 3
PS 3 Yes 21 * 2 Septicaemia 3
PS 3 Yes 26 2 3
KB 2 E No 2 1 2
TF 2 No 12 * 2 3
KT 3 E No 12 * 2 1
BS 3 No 30 * 5 Pneumothorax
Migration
1
AP 5 E No 33 * 5 Septicaemia
Migration
1
ED 3 Yes 7 2 1
PW 3 No 18 * 2 Haematcma 1
JS 3 Yes 1 * 1 1
GF 3 E No 2 * 1 1
AL 3 Yes 33 * 6 Septicaemia
Migration
Thrombosis
2
AS 3 No 1 1 Pneumothorax 3
KD 3 Yes 1 * 1 3
DP 3 No 6 * 1 3
'E' indicates that electrolyte solutions were given in 
isolation, or in addition to a 31itre feeding bag (AP).
* Patients who were continuing treatment at 1.7.84
TABLE 21 : Treatment details for patients who received 
heme parenteral nutrition.
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Table 21 gives details of each patient's treatment.
Complications
Early
Early complications were related to catheter insertion. 
Two patients suffered small pneumothoraces, neither of 
which required intercostal drainage. One patient had a 
haematoma after puncture of the subclavian artery, but 
suffered no serious sequelae.
Delayed
Catheter sepsis was an infrequent problem. Three 
patients developed septicaemia, one caused by Candida, 
one by pseudomonas species, and one by staphylococcus 
epidermidis which was introduced during a period of 
inpatient psychiatric treatment in another hospital.
Catheter migration occurred on six occasions and was 
felt to contribute to the one episode of subclavian vein 
thrombosis which developed in these patients while 
receiving home parenteral feeding.
A total of 37 catheters were inserted which at first 
sight appears a large number. However, only 11 were 
replaced because of catheter problems, 3 after sepsis, 6
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after migration, and 2 after trauma and leakage. Nine 
catheters were changes electively when a new cuffed 
version of the fine-bore Vygon catheter became 
available, 5 were removed at termination of treatment or 
on the death of the patient, and 1 2 remained in place 
and were functioning well.
No patient suffered metabolic complications from the 
parenteral feeding. Several exhibited minor elevations 
of serum transaminases and alkaline phosphatase but 
these were of no clinical significance.
Clinical Outcome and Rehabilitation
The duration of individual courses of treatment ranged 
from 1-33 months, a total of 213 patient-months (16.5 
patient-years). On 1.7.84 twelve patients were
continuing treatment, three had stopped as parenteral 
feeding was no longer needed, and two had died of their 
primary disease and its complications. The parenteral 
feeding did not contribute to either death. Of the 12 
continuing treatment, 6 were well with no evidence of 
active disease. Two, CD and PS continued to require 
treatment for active Crohn's disease. Abdominal pain was 
a major problem for TF and DP and the patients with 
systemic sclerosis and pseudo-obstruction continued to
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have bouts of vomiting and abdominal distension.
Rehabilitation can be graded on four levels. At best, 
grade 1 , patients are leading a near normal life, 
working full time or running the home and able to 
socialise fully. In grade 2, patients work part-time or 
run the home with help. Social activities are somewhat 
restricted. In grade 3, although independent as regards 
their treatment, patients are unable to work and only 
able to get out occasionally. At worst, patients in 
grade 4 are unable to cope with their parenteral feeding 
unaided and are virtually housebound. Of the twelve 
patients still receiving home parenteral feeding, six 
can be classed as grade 1 , one as grade 2 , and five as 
grade 3. Of the five who stopped treatment, two 
attained grade 1, one grade 2, and two grade 3. It is 
important that no patient was in grade 4 except in the 
terminal stages of illness when inpatient treatment was 
needed.
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DISCUSSION
In this chapter the results of the experimental work of 
the thesis are discussed, and their implications for 
clinical management assessed. Guidelines for the 
treatment of patients are proposed.
Electrolyte Mixtures
The studies of water and sodium absorption from 
different sugar-electrolyte solutions have identified a 
useful oral replacement solution which is now being used 
routinely in patients with a short small intestine, and 
have suggested directions in which further investigation 
may proceed.
Glucose and maltose have been shown to promote more 
sodium and water absorption in these patients, than 
sucrose.This may be because only the glucose portion of 
the sucrose the fructose promotes sodium absorption only 
secondary to solvent drag. Although glucose is well 
absorbed from solutions of glucose oligosaccharrides 
(127), the solution c o n t a i n i n g  C a l o r e e n  was 
disappointing. It is possible that the osmotic load 
produced by the rapid hydrolysis of the polymer by 
pancreatic amylase reduces absorption in these patients.
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In their demonstrations of the efficacy of glucose 
polymer in promoting sodium and water absorption, the 
effect of amylase was eliminated by Jones et al (127) in 
their jejunal intubation study with a proximal occlusive 
balloon and minimised by Griffin et al (87) by their 
administration of the 750ml of test solution to their 
patients by slow intestinal infusion over 90 minutes.
Sodium concentration appears to be important in 
determining the efficacy of oral replacement solutions. 
In this thesis, sodium concentration was varied to 
maintain the overall osmolality of the solutions close 
to that of plasma. This resulted in a range of sodium 
concentration from 83mmol/l in the Caloreen mixture to 
115mmol/l in the maltose and sucrose mixtures. The low 
sodium concentration may partly explain the poor 
performance of the Caloreen mixture, but does not 
explain the low absorption from the sucrose solution. 
Conversely, the higher sodium concentration of the 
maltose solution may be partly contributing to the 
increased absorption achieved compared with the glucose 
containing solutions in which the sodium concentration 
was 90mmol/l.
The mixture containing glucose, saline and bicarbonate 
was the best compromise among those tested and has been 
successfully used in many patients with the short bowel
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syndrome and ileostomy diarrhoea. It is however, not 
ideal, as some patients find it unpalatable. Based on 
the results presented, further studies could be aimed at 
ascertaining whether increased sodium concentration is 
indeed associated with improved sodium and water 
balance, and experiments with different flavourings may 
improve palatability.
The inability of patients in Group B to absorb 
sufficient quantities of sodium and water to remain well 
despite having a theoretically sufficient length of 
intestine raises the possibility that they had residual 
inflammatory bowel disease which, although not 
detectable radiologically, was disrupting intestinal 
function at a cellular level, producing a secretory 
state. Perfusion studies would be necessary to 
determine whether this is indeed the case.
Solid Food Diets
The solid food diets used contained different quantities 
of fat and fibre while maintaining other constituents 
constant in an attempt to ascertain which, if any, was 
most beneficial for patients with a short bowel. There 
has been recent debate concerning the need for the 
traditional low fat diet (23,86,124,172) after the
139
results obtained by Woolf et al (281) and Simko et al 
(236) which showed that an increased fat intake is not 
uniformly detrimental (281), and may be beneficial in 
some (236).
Reduction of dietary fat and fibre made no appreciable 
difference to effluent weight, calorie absorption, and 
nitrogen balance. Higher dietary fat intake did produce 
higher faecal fat levels, in agreement with previous 
reports (23,25,227). However, the increased faecal fat 
losses were not associated with increased electrolyte 
and mineral losses for the group as a whole, confirming 
the results of Woolf et al (281).
The traditional guidelines for a low fat diet emanate 
from studies performed on a small group of patients who 
retained different lengths of bowel, some with a colon 
in situ, and some without (23,25). The same is true of 
the more recent studies, where the results obtained from 
a heterogeneous group of patients have been analysed 
together and expressed as a mean for the group with wide 
standard deviations (281), or where a single patient has 
been studied (236).
The patients presented here are also a heterogeneous 
group, with different lengths of intestine, different 
pathologies, and different degrees of disability. The
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results for each individual reveal that in some cases a 
particular diet conferred some benefit although this was 
not significant in the group as a whole. The same 
phenomenon was noted by Booth et al (23,25), some 
patients responding well to fat restriction, and others 
not. Thus it may be suggested that because no two short 
bowel patients are identical, a single dogmatic approach 
to dietary treatment is inappropriate.
All the patients in this study had a stoma. It is 
possible that patients with a colon will respond badly 
to increased dietary fat, and experience worse diarrhoea 
because of the cathartic effect of unabsorbed fatty 
acids (54) and bile salts (110). Thus, these findings 
can not be extrapolated to all patients with a short 
intestine but do support the development of a more 
liberal attitude to the amount of dietary fat which 
these patients are allowed.
Liquid Diets
Although in the normal state digestion and absorption of 
food is well-nigh completed in the proximal 1 0 0 cm of 
jejunum, (28) and elemental diets have been shown to be 
no better a means of providing nutrition than polymeric 
diets in patients with a normal small intestine
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(67,126), intestinal transit is much more rapid in the 
short bowel syndrome, and foodstuffs may thus traverse 
the bowel before digestion is complete. In such cases 
predigested food might be expected to be more completely 
absorbed notwithstanding the presence of an intact 
pancreaticobiliary system. To test this hypothesis, a 
polymeric diet and a chemically defined diet were 
compared in a group of patients who might reasonably be 
expected to benefit from predigestion of foodstuffs.
There were however, no significant differences between 
the two diets. Each patient absorbed similar 
percentages of nitrogen, fat and calories from each 
diet, neither of which significantly reduced the weight 
of stoma effluent when compared with the other. 
Although both feeds produced positive balances of 
potassium, calcium and magnesium, all patients had a 
strong tendency to sodium depletion. This agrees with 
previous findings that patients with an ileostomy are 
unable to retain sodium (102,106) and this tendency is 
exaggerated in patients with a short bowel because of 
the larger volumes of their stoma losses. It is 
therefore extremely important that such patients receive 
sufficient sodium in their diet, and use an oral 
electrolyte replacement solution when necessary.
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These studies of liquid diets have shown that the 
presentation of protein as peptides, carbohydrate as 
oligosaccharrides, and fat as medium chain instead of 
long chain triglycerides is not beneficial even to 
those patients with an extremely short small intestine.
The results of the liquid diet studies have, however, 
shown that these preparations should be useful in 
patients with a short intestine. Although earlier work 
(7) demonstrated no benefit from "synthetic" diets, the 
results in these p a t i e n t s  show that in some 
cases, absorption of nitrogen and calories was greater 
from the liquid diets than from the solid food diets. 
These results are shown in Table 22 which is compiled 
from Tables 5,12 and 13. Although these differences are 
not large enough to justify the substitution of a normal 
diet with a liquid preparation, satisfactory results 
could be achieved by using liquid food supplements for 
patients who are unable to eat enough normal food to 
maintain a good nutritional state.
Some patients are unable to tolerate large quantities of 
liquid supplement orally, and in such cases nasogastric 
administration of feeds may be useful. The study 
comparing oral with nasogastric administration of the 
same feed is too small to allow firm conclusions, but 
there is a suggestion that slow nasogastric feeding may
Calories
1
Solid Diet 
2 3
Liquid
Ensure
Diet
Nutranel
JG 72.1 50.5 68.2 73.1 77.5
DM 65.4 63.9 50.8 73.5 75.5
AP 29.4 23.9 44.5 70.0 48.1
BS 41.9 39.4 50.1 36.7 38.8
Fat
1
Solid Diet 
2 3
Liquid
Ensure
Diet
Nutranel
JG 57.7 38.4 51.9 57.1 10.1
DM 62.3 71.2 75.4 73.0 77.8
AP 34.0 41.9 33.8 31.3 40.0
SB 61.2 35.6 38.7 59.8 45.6
TABLE 22 : Percentage absorption of calories and fat 
from solid and liquid diets.
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be more efficient than simply drinking a liquid 
supplement. Even if this is not the case, the use of 
the nasogastric technique to allow 24 hour feeding and 
thus increase the total calorie intake may produce 
satisfactory enteral nutrition and avoid the need for 
parenteral therapy. In inpatients, the nasogastric tube 
can remain in place continually, with food taken in 
addition to the nasogastric feed. For patients needing 
treatment at home, self-intubation at night allows a 
normal daytime life style, with nocturnal nasogastric 
supplements.
Home Enteral Nutrition
The theoretical reasoning behind the use of liquid 
dietary supplements has been confirmed by the clinical 
studies with patients who had failed to thrive on a 
normal diet, but who all achieved satisfactory weight 
gain while receiving nocturnal nasogastric feeding at 
home. It is particularly encouraging that these results 
were achieved with no mechanical or metabolic 
complications, and that a technique which on initial 
description appears somewhat offputting, should be 
aesthetically acceptable to, and well tolerated by 
patients. Nocturnal tube feeding does therefore have an 
important part to play in breaking the 'nutritional
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deadlock' which develops in patients with a short 
bowel, or as a result of chronic intestinal disease as 
was the case in two patients and in previous reports 
(98,161).
Home Parenteral Nutrition
Although the judicious and energetic use of electrolyte 
replacement solutions and dietary supplements, either 
orally or by nasogastric tube, will produce a rapid and 
sustainable improvement in the health of many patients 
with a short intestine, there remain those for whom 
there is no alternative, other than inanition and death, 
to longterm parenteral nutrition. The development of 
suitable catheters and solutions, reliable equipment, 
and aseptic nursing techniques combinmed with 
enthusiastic patient teaching and support has made 
treatment at home rather than in hospital a feasible 
proposition.
At the time of writing, the patients reported 
represented one of the largest groups undergoing home 
parenteral nutrition in the United Kingdom. Comparison 
with earlier reports (36,120,121,122,145) is encouraging 
in that metabolic complications have been avoided, and 
the level of rehabilitation has been generally aceptable
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to both patients and their medical and nursing 
attendants.
While it is possible that some patients will experience 
sufficient intestinal adaptation to be able to stop 
parenteral supplements (120,122), it is likely that 
treatment for the majority will be lifelong. In such 
cases, an exclusively parenteral diet may be lacking in 
certain trace elements and/or vitamins, deficiencies of 
which may take many months or years to develop. The 
identification of deficiency syndromes (69,123,135,173, 
280) and the ability to measure trace elements in blood 
and tissue specimens should help to ensure that longterm 
parenteral nutrition does not merely lead from one state 
of malnutrition to another. The encouragement of oral 
diet whenever possible may help to provide trace 
elements, the exact requirements of which remain as yet 
unknown.
Of the patients presented here, it is possible that PS 
and TF may adapt sufficiently to thrive on oral diet 
again, and that GF and RT may have periods when oral 
electrolyte replacement is sufficient for there needs. 
The outlook for the remainder is lifelong treatment but 
from the experience gained to date, this should be 
compatible with a good quality of life.
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The overall outlook for patients with a short intestine 
is thus less dismal than before. The availability of an 
effective electrolyte mixture and liquid feeds for 
dietary supplementation mean that chronic dehydration 
and malnutrition can be dealt with by the enteral route 
in many cases. The findings that increased amounts of 
dietary fat can be tolerated by such patients without 
producing detrimental biochemical upset encourage the 
use of more palatable diets, which should also lead to 
better nutritional status. Finally, for those in whom 
more conservative measures are unsuccessful, parenteral 
nutrition at home has been shown to be an effective, low 
risk treatment which is acceptable to patients in the 
longterm and which can result in a return to a normal 
role as spouse, parent, and breadwinner often after 
many years of poor health and limited social function.
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APPENDIX
K B_____ dob 1.8.63
This, girl had a life-long history of ill health 
beginning at the age of eighteen months with attacks of 
pain and altered bowel habit. She failed to thrive 
until 1969 when she developed an anal fissure. Crohn's 
disease was diagnosed. In 1973, after treatment with 
prednisolone had failed to control her symptoms, a left 
hemicolectomy and colostomy was performed. The 
remaining colon and rectum was resected in 1974 and an 
ileostomy raised. Epigastric pain and high volume stoma 
losses became a problem in 1978 and proved resistant to 
medical treatment. Forty-five centimetres of diseased 
ileum were resected, but she developed a postoperative 
e n t e r o c u t a n e o u s  fistula w h i c h  failed to h e a l  
spontaneously and recurred after surgery. Investigation 
of abdominal pain in 1979 revealed a stricture in the 
duodenum which was bypassed surgically. Her fistula 
persisted and she was referred to St Mark's Hospital in 
February 1980.
At that time her stoma output was 4-6 litres daily, she 
had a suprapubic abcess and fistula, a gastroduodenal 
stricture and was malnourished. She weighed only 29.5kg 
and was 145.5cm tall. At laparotomy in April 1980 she
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was found to have severe duodenal deformity and a 
gastrojejunal fistula. A partial gastrectomy and 
gastroduodenal anastomosis was performed with resection 
of the old small bowel fistula, following which 105cm of 
jejunum remained in situ. Histological examination of 
the resected bowel demonstrated Crohn's disease in all 
specimens. Postoperative abdominal pain and vomiting 
persisted, and in May 1980 gastroscopy demonstrated a 
stricture of the gastroduodenal anastomosis which was 
dilated. Despite these measures, chronic abdominal pain 
and opiate dependence together with a large volume stoma 
effluent continued to dominate her clinical course. She 
was taught to administer her intravenous fluids herself, 
and after the jejunostomy had been reconstructed in 
August, she was discharged home in September 1980 on 
home parenteral nutrition. She had a further minor 
procedure performed on the stoma in October but was well 
enough to stay at home until late December thereafter, 
maintaining fluid and electrolyte balance with 
intravenous saline each night. Throughout 1981 she 
continued to suffer chronic, severe pain, partly due to 
gastric ulceration which responded slowly to prolonged 
treatment with intravenous cimetidine. A high stoma 
output, post-transfusion hepatitis, and latterly urinary 
frequency and incontinence further complicated her 
management. She remained on parenteral nutrition 
continually, but finally died in June 1981.
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W D dob 23.8.32
This man was well until 1956 when he developed abdominal 
pain for which appendicectomy was performed. Ileal 
Crohn's disease was suspected. He remained well until 
1973 when he developed an intra-abdominal abcess which 
was treated by right hemicolectomy and ileocolic 
anastomosis. Recurrent disease necessitated resection 
of the anastomosis and 35cm ileum in 1975. He then 
suffered intermittent diarrhoea and weight loss until 
1980. Despite dietary supplements of Casilan, Caloreen 
and Vivonex he lost 6kg in nine months with persistent 
h y p o a l b u m i n a e m i a  tre a t e d  by r e p e a t e d  a l b u m i n  
transfusions in addition to prolonged treatment with 
prednisolone and sulphasalazine. He was referred to St 
Mark's Hospital in June 1980.
Investigations confirmed steatorrhoea and a protein- 
losing enteropathy. A b a r i u m  f o l l o w - t h r o u g h  
demonstrated recurrent anastomotic Crohn's disease which 
was resected with 63cm ileum leaving approximately 150cm 
proximal small bowel. Cholecystectomy was performed for 
chronic cholecystitis and gallstones. Throughout 1981 
he was well, but subsequently began to lose weight in 
January 1982 with recurrent hypoalbuminaemia. Barium 
follow-through revealed further anastomotic recurrence 
and a short residual small intestine which measured
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130cm. In an effort to preserve as much bowel as 
possible resection was avoided. Treatment with 
prednisolone was started and he began to supplement his 
diet with Nutranel in February 1982. Although he was 
initially successful in taking a supplement of 1600- 
2000kcal daily, palatability became a problem after 
discharge. In June 1982 he began nasogastric 
supplements using a similar quantity of Nutranel with 
good weight gain in the next few months.
T F_____ dob 22.6.55
This lady first developed mouth ulceration in 1970 which 
recurred in 1971 in association with perianal abcesses, 
generalised malaise and lassitude and a refractory 
microcytic anaemia. She developed diarrhoea and weight 
loss shortly afterwards and was investigated at her 
local hospital. Faecal fat excretion, xylose absorption 
and jejunal biopsy were normal. Radiology revealed 
duodenal dilatation only. She was placed on a gluten- 
free diet which continued until 1975 with little change 
in her symptoms.
She was referred to St Mark's Hospital in 1975 with 
diarrhoea, abdominal and anal pain and weight loss to 
less than the third percentile. Her height was between
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third and tenth percentiles, bone age 19-21 years. 
Radiology showed Crohn's disease affecting terminal 
ileum, colon, and rectum with multiple perianal 
fistulae. Despite treatment with prednisolone and 
azathioprine she developed a rectal stricture. 
Proctocolectomy and ileostomy were performed in July 
1976. The ileostomy output remained greater than 
1 litre daily despite codeine phosphate and loperamide.
In 1977 postprandial abdominal pain and vomiting 
secondary to recurrent jejuno-ileal disease was treated 
with metronidazole, cotrimoxazole and prednisolone. She 
failed to gain weight and parenteral nutrition was given 
from September to December 1977. Over the next year her 
stoma was revised surgically because of leakage of 
effluent and she continued to take inadequate amounts of 
food because of pain and high volume stoma losses. 
Parenteral nutrition was re-introduced in May 1978 and 
she continued this treatment at home from July 1978 to 
April 1979 in addition to prednisolone and azathioprine.
After discontinuing parenteral nutrition, salt and water 
depletion became a major problem in 1980. She developed 
subacute small intestinal obstruction secondary to 
adhesions which were lysed at operation, when no active 
Crohn's disease was seen. Continued low weight and low 
sodium status prompted admission for nasogastric feeding
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which was successful in achieving her optimum weight. 
She was not prepared to administer this treatment at 
home however, and her weight decreased after discharge. 
Abdominal pain, resistant to antispasmodics, mild 
analgesics and occasionally to pethidine became an 
increasing problem in 1982. An exploratory laparotomy 
revealed no recurrent disease, and no obstructing 
adhesions. Azathioprine and prednisolone were stopped.
Since 1982 she has been unable to take sufficient 
calories, fluid and electrolytes orally to allow her to 
thrive. The ileostomy continued to produce greater than 
1 litre of effluent daily, and she has suffered 
recurrent oral ulceration and arthralgia of the right 
knee. A further trial of nasogastric electrolyte 
replacement was unsuccessful and home parenteral 
nutrition was restarted in May 1983. This has 
maintained her weight and a satisfactory nutritional 
status but has not improved her symptoms. She is unable 
to work, but looks after the home with help from her 
husband.
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J G dob 28.6.31
This lady had never been seriously unwell until March 
1978 when cervical carcinoma was diagnosed. A vaginal 
hysterectomy was followed by a six week course of 
radiotherapy and a radium implant for local spread. She 
was vaguely unwell during treatment.
In January 1980 an attack of 'gastroenteritis' with 
abdominal pain was followed in February by emergency 
admission and laparotomy. A small bowel perforation was 
treated by resection and end-to-end anastomosis from 
which she made an uneventful recovery. Her bowel habit 
remained variable in frequency and consistency however, 
requiring regular treatment with codeine phosphate.
Readmission was precipitated by an episode of subacute 
small bowel obstruction in August 1981. At laparotomy 
the terminal ileum was found to be gangrenous and a 
modified right hemicolectomy was performed. Breakdown 
of the anastomosis necessitated further laparotomy, 
colectomy and mucous fistula with a terminal ileostomy 
being performed. The total length of small intestine 
resected was said to be 100cm. Her postoperative course 
in an Intensive Therapy Unit was complicated by two 
pneumotharaces and left subclavian vein thrombosis 
secondary to attempts at central venous catheterisation
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and parenteral nutrition. She developed a stoma output 
of between 2 and 7 litres daily with rapid weight loss 
and was referred to St Mark's Hospital in November 1981.
She had lost 12.5kg, was lethargic and complained of 
muscle cramps. There was hypomagnesaemia which required 
parenteral replacement. Her stoma output settled from a 
maximum of 13 litres to 1.5-2 litres daily at the time 
of discharge in February 1982. Oral replacement of 
s od i u m  and w a t e r  losses was p o s s i b l e  u s i n g  a 
glucose/electrolyte solution in addition to codeine 
phosphate, loperamide and magnesium hydroxide 
supplements.
Throughout 1982 she required repeated admissions for 
intravenous saline infusions. It proved impossible to 
train her to safely administer parenteral fluids or to 
look after a central venous catheter with satisfactory 
aseptic technique. She therefore started nasogastric 
administration of a glucose/electrolyte mixture 
overnight, giving 2 litres each night and drinking a 
further 1-2 litres by day. Supplements of zinc sulphate 
and essential fatty acids as topical sunflower seed oil 
were added in June 1982.
In J a n u a r y  1983 she deve l o p e d  h y p o c a  1c a e m i a , 
hypomagnesaemia and dehydration secondary to an increase
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in her stoma output to 5 litres daily. Despite a good 
appetite, weight loss was a problem. The addition of 
fludrocortisone resulted in reduction of her daily 
output to 1.2 litres. Supplements of magnesium, zinc, 
electrolytes and fatty acids continued from discharge in 
March 1983.
Continuing weight loss remained a problem and in May 
1983 she began to administer a calorie supplement by 
nasogastric tube at night using Ensure with good 
results. She stopped fludrocortisone and other 
supplements of her own accord in November 1983 and 
gradually deteriorated until their reintroduction in 
March 1984 since when she has remained well.
S G dob 2.11.44
This gentleman first had problems with Crohn's disease 
in 1961. Diarrhoea, pain and weight loss were 
successfully treated with medical therapy until 1972 
when an exacerbation required right hemicolectomy and 
ileal resection. He remained reasonably well until 1976 
when colonic involvement was diagnosed, and anorectal 
disease became his major problem in 1977. Pelvic sepsis 
complicating the colitis was treated by sigmoid 
colectomy and colostomy that year. He suffered
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recurrent episodes of subacute small bowel obstruction 
over the next five years, and on one occassion was 
admitted to St Mark's Hospital. Abcess formation, 
active colonic disease and small bowel obstruction 
required surgical treatment, with resection of the 
remaining colon and rectum, and diseased small 
intestine, leaving 130cm proximal gut in situ. He lost 
large volumes from his jejunostomy, usually of the order 
of 3 litres daily, which responded poorly to codeine and 
loperamide. Sodium and water losses were replaced using 
an oral glucose/electrolyte mixture and he has been able 
to maintain a satisfactory weight by eating a large 
diet, and tolerating the consequent large volume of 
stoma effluent.
D M dob 19.7.34
This man presented with symptoms of acute appendicitis 
in 1966. At appendicectomy; ileal Crohn's disease was 
diagnosed and treated expectantly. Following three 
years of variable health with diarrhoea, abdominal pain 
and weight loss, an ileo-transverse colostomy was 
performed, bypassing the diseased ileum. He remained 
well for 18 months but then developed a low output 
enterocutaneous fistula in the right iliac fossa which 
persisted until 1972 when he was referred to St Mark's 
Hospital.
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Examination revealed anal Crohn's disease, and radiology 
demonstrated terminal ileal disease with normal proximal 
small bowel and colon. An extended right hemicolectomy 
was performed with resection of 90cm ileum and side-to- 
end ileocolic anastomosis in December 1972. Crohn's 
disease was confirmed on histological examination of the 
specimen. He suffered recurrent wound abcesses 
throughout 1973 and in December 1974 he developed 
obstructive symptoms. Colonoscopy revealed recurrent 
disease at the anastomosis which proved resistant to 
treatment with oral prednisolone. At laparotomy in 
March 1975 a duodeno-ileal fistula was demonstrated at 
the anastomosis which was the site of his recurrent 
abcesses. Anastomotic resection and reanastomosis was 
perfomed, removing 23cm ileum. A further anastomotic 
recurrence, resistant to medical therapy required 
resection in 1977 when the remaining small intestine 
measured 225cm.
Over the next year he gradually lost weight and suffered 
i n t e r m i t t e n t  d i a r r h o e a  and a b d o m i n a l  p a in. 
Investigation in 1978 revealed anastomotic recurrence 
with new rectal involvement and deterioration of the 
anal lesion. Proctocolectomy and ileal resection was 
performed leaving 150cm proximal small bowel in situ. 
The postoperative course was complicated by abdominal 
abcesses, empyema of the gallbladder which required
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cholecystotomy and removal of gallstones, and a chronic 
perineal sinus. His jejunostomy output was consistently 
greater than 2 litres daily and his weight remained low 
at 68kg.
In S e p t e m b e r  1979 he w e i g h e d  59.4kg and full 
reassessment was undertaken. There was steatorrhoea and 
lactose intolerance with a normal pentagastrin 
stimulation test. Treatment with a low fat diet, 
cimetidine and antidiarrhoeal medications failed to 
consistently decrease the stoma output. His diet was 
supplemented with medium chain triglycerides to 3500kcal 
per day. On this diet and supplements of ox bile and 
cimetidine his weight gradually increased but he became 
intolerant of MCT and stopped the supplements.
In May 1980 he was taught to pass a nasogastric feeding 
tube himself and thereafter took 4 cans Isocal at night, 
decreasing to 3 cans after three months. He continued 
treatment for one year and then attempted to withdraw 
the supplements. Rapid weight loss followed which was 
reversed by restarting the nocturnal feeds. In 
September 1981 he did manage to revert to oral 
supplements by day and to dispense with nasogastric 
feeds and has remained well since.
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A P_____dob 27.12.37
In 1962 this lady developed diarrhoea and abdominal pain 
for the first time. A radiological diagnosis of Crohn's 
disease was made. She received medical treatment until 
1965 when, following several attacks of subacute small 
bowel obstruction, a right hemicolectomy with ileocolic 
anastomosis was performed. Crohn's disease was 
confirmed histologically. In 1966 a second laparotomy 
was performed for small bowel obstruction. Adhesions 
responsible for the obstruction were lysed and the 
intestines reported as being normal throughout. She 
remained well until 1968 when recurrent abdominal pain 
prompted radiological investigation. Recurrent Crohn's 
disease at the ileocolic anastomosis was diagnosed and 
subsequently resected with reanastomosis of the bowel.
In 1970 she developed perianal Crohn's lesions which 
were treated with prednisolone and azathioprine. For 
the next eight years she was troubled by recurrent 
fistulae-in-ano which required local surgical procedures 
resulting in variable continence exacerbated by loose 
stools and general malaise. Radiological reassessment 
in 1978 revealed recurrent small bowel disease which 
failed to respond completely to medical treatment 
including prednisolone and azathioprine. By 1981 
jejuno-ileal, colonic and anal diease with a recto­
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vaginal fistula were causing severe diarrhoea, abdominal 
pain, incontinence and social embarrassment. Further 
treatment with systemic prednisolone, azathioprine, an 
elemental diet and antibiotics was unsuccessful. A 
proctocolectomy with jejuno-ileal resection was 
performed and a terminal jejunostomy raised in May 1981. 
Approximately 120cm of healthy jejunum remained.
She subsequently developed problems with high volumes of 
stoma effluent, from 3-5 litres daily with associated 
thirst, syncope, nausea and a noticably rapid intestinal 
transit of approximately 10 minutes. Treatment with 
codeine phosphate, lomotil, low residue diets and oral 
electrolyte replacement solutions was unsuccessfull and 
she required intermittent infusions of intravenous 
saline to maintain fluid and electrolyte balance. She 
was transferred to St Mark’s Hospital in August 1981.
At that time she weighed 45.5kg, with a smooth beefy 
tongue with angular cheilosis and a fasting stoma output 
of 2.5l/24hours. It was not possible to reduce her 
output using cimetidine, loperamide, codeine phosphate, 
fludrocortisone or propantheline in maximal dosage. A 
subclavian catheter was inserted for the purposes of 
electrolyte repletion and she was discharged in 
September 1981 administering 3 litres of saline 
intravenously each night. She was well enough to take a
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holiday in Malta in December 1981 taking her intravenous 
solutions with her.
In January 1982 it was noted that she was continuing to 
lose weight. Her jejunostomy had retracted causing 
effluent leakage. The stoma was refashioned and the 
remaining intestine measured 60cm. A further attempt 
was made to control her high volume output with medical 
therapy, but all measures including oral prednisolone 
proved unsuccessful. She commenced supplementary home 
parenteral nutrition in March 1982 and has continued to 
require 5 litres of intravenous fluids daily to maintain 
a satisfactory nutritional state. Despite these 
problems she has returned to work as a part-time school 
secretary, and is fully able to look after her home and 
family and to enjoy a satisfactory social life.
B S dob 11.5.1937
This lady developed inflammatory bowel disease in 1974 
and required emergency admission with toxic dilatation 
of the colon in 1979. A panproctocolectomy was 
performed, complicated postoperatively by persistent 
sinuses in the left iliac fossa and perineum. Over the 
next 3 months her general condition deteriorated and 
further investigation revealed an enterocutaneous
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fistula communicating via an abcess cavity in the left 
side of the abdomen with the jejunum. Attempts at 
percutaneous drainage with a 'skinny' needle were 
unsuccessful. She underwent laparotomy with drainage of 
the abcess and resection of 12cm jejunum in December 
1979 with a stormy postoperative course and parenteral 
feeding.
From April until August 1980 she remained reasonably 
well despite a persistent discharge from the abdominal 
and perineal wounds. Barium meal and follow through 
showed no abnormality but a sinogram demonstrated a 
recurrent fistula communicating with the small bowel.
She was transferred to St Mark's Hospital in September 
1980. There was weight loss of 19kg, persistent pyrexia 
and intermittent abdominal pain and diarrhoea. 
Laparotomy was performed in October 1980 when a jejunal 
fistula communicating with a left subphrenic abcess, an 
enterocutaneous fistula communicating with two loops of 
small intestine, and a perineo-vaginal fistula were 
identified. Four limited small intestinal resections 
were performed, leaving a total of 285cm from duodeno­
jejunal flexure to ileostomy. The perineo-vaginal 
fistula was laid open. Parenteral nutrition was needed 
for support in the postoperative period. Histology of 
all resected specimens was diagnostic of Crohn's
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disease. She was finally discharged in November 1980.
After only two weeks at home, she was readmitted with a 
left-sided abdominal abcess which required surgical 
drainage following which nasogastric feeding produced 
weight gain of 8kg. Azathioprine was introduced but she 
developed side effects necessitating cessation of 
treatment before discharge in March 1981.
Emergency readmission was necessary in May 1981. At 
laparotomy, multiple small perforations of the small 
intestine were found. Four short segments of bowel were 
resected. Multiple enterocutaneous fistulae developed 
postoperatively and parenteral nutrition was again 
needed, but her fistulae persisted. A further 
laparotomy was performed in August 1981. A large pelvic 
abcess was drained and small intestine containing a 
fistula was resected. The remaining small bowel 
measured 100cm. A recurrent low output enterocutaneous 
fistula was treated with metronidazole and erythromycin 
and healed spontaneously. The jejunostomy output was 
between 3 and 6 litres daily despite loperamide, codeine 
phosphate, lomotil, fludrocortisone and cimetidine. It 
was initially possible for her to replace these losses 
with intravenous saline, but gradual weight loss despite 
a good food intake necessitated the reintroduction of 
supplementary parenteral nutrition. She was discharged
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in January 1982 and has continued home parenteral 
feeding.
Since 1982 this lady has managed to cope with a 
difficult home environment and looks after her family 
and home independently. She took a part-time job in a 
dry-cleaning firm in August 1983, and now works full­
time .
M S_____ dob 22.2.59
This young lady had her first attack of ulcerative 
colitis in 1979. Although there was dilatation of the 
colon she responded to treatment with oral and rectal 
prednisolone and sulphasalazine. All treatment was 
stopped by May 1980. She required oral prednisolone for 
a relapse in July 1980 and suffered a further attack in 
November despite prophylactic oral prednisolone and 
sulphasalazine. Barium enema showed severe pseudopolyp 
formation and a total colitis. Her attack settled and 
she was referred to St Mark's Hospital for consideration 
of elective surgery in March 1981.
An acute relapse with colonic dilatation needed urgent 
surgery in April 1981 at which time the colon was found 
to have perforated and the peritoneal cavity was
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contaminated with faeces. Colectomy with mucous fistula 
and ileostomy was performed. During the next nine months 
she required parenteral nutrition to support her through 
recurrent abdominal abcesses with small bowel fistulae. 
She required five further major surgical procedures 
resulting in multiple resections of small intestine and 
the rectal stump. She retained 110cm jejunum with a 
loop stoma at 80cm. She was discharged in March 1982 
taking a normal diet and oral electrolyte supplements 
despite which she lost weight rapidly and was readmitted 
for reassessment in August 1982. She was taught to pass 
a nasogastric feeding tube herself and was discharged in 
September 1982 administering 4 cans Ensure each night 
and drinking a further 4 cans each day in addition to a 
normal diet. She continued this regime until January 
1983 and since then has used the nasogastric tube mainly 
for electrolyte replacement and occassional nutrient 
supplements. She continues to take 2 cans Ensure orally 
each day, and now works full time as a secretary. 
Further surgery to close her loop stoma is planned.
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R T dob 2.6.1939
This gentleman initially became unwell in 1965 when an 
appendicectomy was performed. At that time suspicions 
of Crohn's disease were raised and later that year a 
terminal ileal resection was carried out. Histological 
examination of the resection specimen confirmed the 
diagnosis. He remained well on minimal treatment until 
1972 when loss of weight was associated with abdominal 
pain and a right iliac fossa mass. He was treated with 
oral prednisolone for 4 months with moderate success.
In 1979 he required three hospital admissions for 
subacute small bowel obstruction. All episodes 
responded to conservative management, including 
intramuscular and oral steroids, sulphasalazine and a 
low residue diet. Investigation of low back pain 
revealed minor degenerative changes in the lumbar spine. 
Following a further admission for small bowel 
obstruction in early 1980 he underwent resection of the 
ileocolic anastomosis including 15cm ileum and 10cm 
colon. Histology confirmed recurrent Crohn's disease.
He remained asymptomatic until 1982 when abdominal pain 
and diarrhoea was accompanied by weight loss from 60kg 
to 54.6kg (ideal 62kg). Full reassessment was 
undertaken, including colonoscopy which showed the
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colon to be grossly abnormal from sigmoid to splenic 
flexure. Medical treatment with prednisolone and 
azathioprine was unsuccessful, and proctocolectomy with 
a further small bowel resection was undertaken. It 
transpired that his previous resection had been more 
extensive than reported, and following this resection of 
35cm, only 100cm of small bowel remained, terminating in 
an end jejunostomy. Histology of the specimen again 
showed Crohn's disease. Despite antidiarrhoeal therapy 
the output from his jejunostomy remained in the range of 
3-5 litres/24hours. He required repeated readmissions 
for intravenous electrolyte replacement and was 
subsequently referred to St.Mark's hospital for 
consideration of home parenteral nutrition in May 1983.
He weighed 40kg and laboratory investigations revealed 
anaemia, hypoalbuminaemia and hypomagnesaemia. After 
studies of food absorption it became clear that he was 
able to maintain a good nutritional state on a large 
diet, provided that the high stoma losses were replaced 
parenterally. He was discharged on codeine phosphate, 
loperamide and oral zinc supplements, and administers 
3 litres of saline with potassium and magnesium 
supplements intravenously each night.
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C W_____dob 21.10.65
This young man first became unwell in 1973 with 
diarrhoea and an anal fissure. Biopsy of this lesion 
revealed a granulomatous process which was treated with 
anti-tuberculous therapy. In August 1974 he required 
surgery for pyloric stenosis secondary to a chronic 
duodenal ulcer. A truncal vagotomy and gastro­
jejunostomy was performed together with appendicectomy 
and biopsy of a mesenteric lymph node. Histology of 
this node suggested 'early Crohn's disease'. He 
remained well until June 1978 when diarrhoea recurred 
with abdominal and anal pain, rectal bleeding, weight 
loss and erythema nodosum. A barium enema revealed 
severe terminal ileal and colonic Crohn's disease. 
Despite prolonged treatment with oral prednisolone he 
failed to thrive and between February 1979 and June 1980 
he lost weight and failed to grow. He was referred to 
St Mark's Hospital in June 1980.
His height and weight were both below the third 
percentile. He was generally unwell, with pallor and 
oedema of both legs. Multiple perianal fistulae 
complicated severe anal Crohn's disease. He started 
treatment with azathioprine in addition to oral 
prednisolone, codeine phosphate and loperamide. 
Nasogastric feeding commenced with 8 cans Isocal and
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additional supplements of iron, zinc and folic acid. He 
was discharged in September 1980 and continued to take 4 
cans Isocal each night by nasogastric tube with 
resultant gain in weight and height. A recurrence of 
his Crohn's colitis and the development of a colo- 
vesical fistula was accompanied by a cessation of growth 
and weight gain and necessitated proctocolectomy in 
February 1981. Following a recovery complicated by 
pelvic abcess and vesico-cutaneous fistula formation, he 
has required no further nasogastric supplements and has 
exhibited excellent catch-up growth and weight gain 
which is shown in Figure 41.
I W dob 12.7.13
This lady developed severe diarrhoea and weight loss in 
1976. Radiological investigation demonstrated 
ileocolonic Crohn's disease which proved resistant to 
m e d i c a l  t h e r a p y .  In 19 7.7 she u n d e r w e n t  
panproctocolectomy, and an ileostomy was fashioned. 
Although the entire small intestine remained, she had 
high volume losses which were resistant to anti- 
diarrhoeal treatment. She was referred to St Mark's 
Hospital in 1978.
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Despite dietary manipulation and further medical 
treatment she continued to have troublesome ileostomy 
diarrhoea and leakage, which necessitated refashioning 
of the stoma in 1979. There was no evidence of 
recurrent small bowel Crohn's disease at operation. 
During 1980 she required periods of inpatient parenteral 
fluid replacement, but was finally stabilised using an 
oral glucose/electrolyte mixture and returned to the 
supervision of her local hospital.
M W dob 27.9.31
This lady first developed ulcerative colitis in 1961. 
Her disease ran a relapsing course over the next ten 
years during which she required intermittent, and 
latterly continuous treatment with sulphasalazine, and 
topical and oral prednisolone. She was referred to St 
Mark's Hospital for assessment in May 1971.
She was malnourished, with weight loss, hypocalcaemia 
and adrenal suppression. Her treatment was changed to 
intramuscular ACTH with good effect. Relapse of her 
colitis in November 1971 prompted elective colectomy and 
caecorectal anastomosis complicated by a postoperative 
pelvic haematoma and abcess formation. Following 
discharge she was troubled by frequent, loose stools
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exacerbated by continuing inflammation in the rectum.
By April 1980 she had lost more weight secondary to poor 
dietary intake. Small bowel radiology, lactose tolerance 
and faecal fat excretion were all normal. Nasogastric 
feeding was commenced in June 1980 using 3 cans of 
Isocal each night. Abdominal discomfort and bloating 
were treated by reducing her nocturnal supplement to 
2 cans Isocal until proctocolectomy and ileostomy was 
performed in October 1980. She has required no dietary 
supplements since operation.
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